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Chapter 1 
INTRODUCTION AND AIM OF THE STUDY 
1 INTRODUCTION AND AIM OF THE STUDY 
1.1 Notes on the short bowel syndrome 
In defining the short bowel syndrome it is important to have information 
on the length of the normal small bowel in man. However, human small 
intestinal length has not been established exactly. Results of postmortem 
length measurements are extremely variable and therefore useless. Muscle 
relaxation during autolysis results in unpredictable intestinal 
lengthening . Measurements during surgery also have drawbacks, such as 
variable influences of anaesthesia and surgical trauma on intestinal muscle 
tone, different sites of measurement (e.g. at the mesenteric or at the 
antimesenteric border, or just in between). At laparotomy, Backman found 
a mean small bowel length of 6.43 m (range 4.00 to 8.46 m) in 32 patients 
2 
of normal body weight . Duplicate measurements of the small intestinal 
length revealed a mean difference of 101 between each two measurements . 
Probably the most physiological method to assess small bowel length is that 
using a transintestinal intubation technique. With this method, a mean 
length of jejunum and ileum of 2.61 m (range 2.06 to 3.29 m) was obtained 
in 10 subjects . The main disadvantage of this technique is presumably the 
unevaluable degree of "telescoping" of small intestine over the tube during 
the procedure. Altogether, measurements of small intestinal length at 
autopsy or laparotomy generally produce too large values, and those with 
the intubation technique too small values. In practical terms the length 
of the human small bowel presumably varies between about 2.5 and 4 m. 
After an extensive small bowel resection, reliable length measurement 
of the remnant can be perfomed by observations at surgery or by small 
bowel X-ray series after resection . 
Koeberlé was the first to describe a successful extensive small bowel 
resection (2.05 m) in 1881 . In 1935, 257 cases of massive small bowel 
resection were collected from the literature . At that time it was 
concluded that resection of one-third of the small bowel was generally 
well-tolerated. A 50% resection was thought to be the maximum compatible 
with life. In 1956 it was stated that a тіпілит of 35 to 70 cm of small 
intestine was necessary to maintain an acceptable nutritional state . 
An anecdotal report on a patient with duodenotransversostomy who survived 
one year despite 12.5 kg weight loss and recurrent water and mineral 
Q 
disturbances suggests that virtually no jejunum and ileum is necessary . 
2 
However, in the large majority of published case histories of patients with 
10 to 25 cm of remaining jejunum and/or ileum, death ultimately ensued after 
9—17 
variable periods of severe protein-calorie malnutrition . Considering 
these observations, previously proposed definitions of short bowel syndrome 
(SBS) implying symptoms and metabolic alterations occurring after resection 
5 1Θ 
of at least 2 m or 701 of the small bowel, seem valid ' . This means some 
1.00 m or less of remaining small intestine beyond the ligament of Treitz. 
The most frequent causes of SBS in relatively young persons include 
multiple resections for Crohn's disease and volvulus with ensuing necrosis 
of the small bowel. Mesenteric infarction is the major cause of SBS in 
elderly patients. In figure 1* the number of persons who died from mesenteric 
infarction in The Netherlands is indicated frem 1969 until 1980. From 1976 
on, a gradual increase in death rate can be noted, averaging some 250 persons 
per year. Figure 2* graphically presents the mean death rate per 5-year age 
category over the same period. A substantial rise can be observed from age 
60 on. Until age 75 there is hardly any difference between men and wonen, 
but beyond this age women die fron mesenteric infarction more often than 
men. However, in these age categories more women are still alive than men. 
Since parenteral nutrition entered clinical medicine in 1968 , the 
treatment of various disorders has changed more or less. Especially 
patients with massive small bowel resection benefited from this treatment. 
From 1972, several papers have been published on the impact of long-term 
parenteral nutrition at home in this group of patients ~ . In the past 
decade seme reports have dealt with absorption defects and nutritional 
needs in SBS patients on oral nutrition " . 
Since the advent of parenteral nutrition, SBS patients can be divided 
into two groups. 
1 Patients with less than 40 an of jejunum and/or ileum left and 
depending mainly or completely on parenteral nutrition. 
2 Patients with 40 to 100 cm of remaining jejunum and ileum, exclusively 
maintained by oral nutrition. 
*Data obtained from CBS (Centraal Bureau voor de Statistiek; Central 
Bureau of Statistics), Voorburg, The Netherlands 
3 
n u m b e r 
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1969 '71 73 75 7 7 79 
Figure 1.1 
Number of persons who annually die from mesenteric infarction in The 
Netherlands. 
AO-W 45-49 50-54 55-59 60-64 65-69 70-74 75-79 80-64 > 85 
age category 
Figure 1.2 
Mean death rate per year from mesenteric infarction indicated per 
5-year age category in The Netherlands. 
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Apart from SBS, prolonged parenteral nutrition may be necessary for 
patients with a non-resected small bowel without function, e.g. severe 
radiation enteritis, scleroderma involving the small bowel and chronic 
intestinal pseudo-obstruction resistant to medical therapy. Other indications 
for long-term parenteral nutrition are of an incidental nature. 
Patients of group 2 may require a period of total parenteral nutrition 
to maintain homoeostasis while intestinal adaptation of the small bowel 
remnant is developing. Intestinal adaptation, characterized by hyperplasia 
of the remaining epithelium enables increased absorption of oral nutrients 
1.2 Aim of the study 
The aim of the study is to describe clinical and biochemical findings in 
patients with SBS and to present data on absorption of various nutrients, 
including trace elements, and on bone metabolism in these patients. When 
appropriate, patients are divided as described in the previous section: 
those depending on parenteral nutrition and other maintained by oral 
nutrition. Moreover, a review of intestinal adaptation is presented. 
Finally, seme technical aspects of long-term parenteral nutrition are 
amplified in more detail, such as administration systems and vascular 
access procedures. 
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SHORT BOWEL SYNDROME. EXPERIENCES IN EIGHT PATIENTS. 
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2 SHORT BOWEL SYNDROME. EXPERIENCES IN EIGHT PATIENTS. 
2.1 Introduction 
The average length of the small bowel in vivo amounts to approximately 
3 m . Short bowel syndrome (SBS) has been defined as a complex of symptoms 
and metabolic alterations occurring after resection of at least 2 m or 701 
2 3 
of the small bowel ' , implying 1 m or less of remaining jejunum and or 
ileum. Causes of SBS in relatively young persons include recurrent 
resections due to Crohn's disease and volvulus with ensuing necrosis of 
the small bowel. Vascular accidents of the mesenteric circulation are the 
major cause of SBS in elderly persons. 
After an extensive small bowel resection malabsorption of various nutrients 
can be expected, resulting in weight loss, diarrhoea and deficiencies. 
Pathophysiological mechanisms underlying malabsorption and diarrhoea in 
these circumstances include: 
1 Reduced contact time between luminal nutrients and small bowel mucosa 
due to significant loss of absorptive surface and increased transit 
through the shortened intestine. 
2 Abnormal delivery to the colon of maldigested or malabsorbed nutrients, 
precipitating osmotic diarrhoea. 
3 Interruption of the enterohepatic circulation may result in: a) bile salt 
loss into the colon, causing fluid secretion and thus diarrhoea; 
b) increased faecal bile salt loss, which may compromise bile acid pool 
and impair micellar fat absorption, aggravating steatorrhoea. 
After removal of the entire jejunun and ileum, sufficient absorption is no 
longer possible. In this situation heme parenteral nutrition can be life-
4 
saving treatment -. 
This paper describes eight SBS patients on oral nutrition. Clinical and 
biochemical data are presented. Results of absorption and balance studies 
are reported. Consequences of various types of bowel resection and some 
specific metabolic problems are emphasized. Finally, the management of SBS 
patients is discussed. 
2.2 Patients 
Eight patients, six males and two fonales, were studied an average of 
53 months (range 24-87 months) after extensive small bowel resection. Table 
2.1 summarizes clinical data on these patients. In the oldest six patients 
10 
Table 2.1 
EXTENT OF BOWEL RESECTION IN θ PATIENTS WITH SHORT BOWEL SYNDROME. 
Patient 
Sex 
Age at time 
of resection 
Cause 
resection 
Remaining 
jejunum (cm) 
Remaining 
ileum (cm) 
Ileocoecal 
valve 
Resection 
colon 
A 
f 
35 
strangu­
lation 
ileus 
40 
20 
+ 
_ 
В 
m 
47 
sup.mesen­
teric art. 
infarction 
40 
20 
+ 
_ 
С 
m 
57 
sup.meεen­
ter ie art. 
infarction 
90 
20 
+ 
_ 
D 
m 
65 
sup.mesen­
teric art. 
infarction 
40 
0 
_ 
asc. 
E 
m 
18 
sup.mesen­
teric art. 
infarction 
90 
2 
+ 
_ 
F 
m 
16 
volvulus 
small 
bowel 
35 
15 
+ 
_ 
G 
m 
55 
sup.mesen­
teric art. 
infarction 
30 
15 
+ 
_ 
H 
f 
74 
sup.mesen­
teric art. 
infarction 
50 
0 
_ 
asc.+trans' 
* present 
- absent 
mesenteric infarction was the underlying disease causing SBS. The length 
of the small bowel remnant varied from 40 to 110 cm (mean 60 cm). In three 
patients (D,E and H), no or hardly any ileum was left. In two patients (D 
and H) the ileocoecal valve and part of the colon had to be removed as well. 
When discharged from hospital after resection, all patients except one had 
achieved an acceptable equilibrium on oral feeding. Home parenteral 
nutrition during one year after resection appeared to be necessary in 
patient F4. 
2.3 Methods 
Data relate only to the time after discharge from hospital. At out-patient 
clinic visits, body weight was recorded and plasma or serum levels of albumin, 
haemoglobin, cholesterol, Na, K, Ca, Mg, phosphate, copper and zinc were 
measured. At less frequent intervals levels of fat-soluble vitamins E, 
carotene and 25-hydroxyvitamin D, (25 OHD,) and water-soluble vitamins 
folic acid, vitamin B..,, pyridoxine and transketolase (equivalent of vitamin 
В..) were determined. To test the absorptive capacity of the remaining small 
bowel, D-xylose tests were carried out twice or more in the course of time. 
The functional capacity of the ileum remnant was measured using the Schilling 
test. Urinary oxalate excretion was evaluated from time to time. Hyperoxaluria 
may be expected in SBS, predisposing to the formation of urolithiasis. 
An average of 30 months (range 12-60 months) after resection, all patients 
were admitted to hospital for a balance study during five days. During an 
equilibration period of three days and during the balance period patients 
consumed a fixed, self-selected diet to which they had been adapted at home. 
The diets were prepared in advance and in multiplícate, including one for 
analysis. The nutrients assessed during the balance period included nitrogen, 
fat, calcium, magnesium and phosphate. Carmine red served as marker for stool 
collection. From measurements of all materials (diets, stools and urine) the 
balance was calculated and expressed per day. 
2.4 Results 
Figure 2.1 shows the course of the body weight in all patients at out-
patient clinic visits. Body weight are expressed as mean percentage of ideal 
body weight . After an initial small decrease, a gradual increase in body 
weight occurs some 18 months after discharge from hospital. At the moment, 
body weight is more than 854 of the ideal body weight except in patient H 
(724). 
12 
% ideal 
body weight 
110· 
100-
90 
80 
70 n=e 
5 
year 
Figure 2.1 
Body weight expressed as mean percentage of ideal body weight 
(± SEM) in course of time after discharge from hospital. 
n=number of patients at the time of investigation. 
In figure 2.2 the course of serun albumin is presented. In two patients 
(D and E) moderate to severe hypoalbuminaemia was present the first two 
years after discharge. Serum albumin has since ranained normal in all 
patients. 
5 
year 
Figure 2.2 
Mean serum albumin (± SEM) in course of time. The dotted line repre-
sents the lower limit of normal. 
n=number of patients at the time of investigation. 
13 
Mean haemoglobin levels remained within normal limits throughout the 
observation period (figure 2.3). Patients D and E however, also had anaemia 
some M to 2 years after discharge, without evidence of deficiencies of 
iron, folic acid, vitamin B12 and copper. 
haemoglobin (mmol/I 
11 0-, 
100 
90 
80 
70rL 
Figure 2.3 
Mean haemoglobin (± SEM) in course of time. 
n=number of patients at the time of investigation. The area between 
the dotted lines represents normal values. 
Mean plasma levels of sodium were normal (figure 2.4) while initially 
potassium levels were decreased (figure 2.5). 
sodium Immol /1 ) — - — - - - -
H 6 η 
H 4 
142 
140 
1Э 
Mean plasma sodium (± SEM) in course of time. 
n=number of patients at the time of investigation. The area between 
the dotted lines represents normal values. 
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potassium (mmol/1 ) 
U 8 π 
4 U -
40 -
36 
τ/ "" 
г 
IAJ 
I 
ш 
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Figure 2.5 
Mean plasma potassium (± SEM) in course of time. 
n=number of patients at the time of investigation. The area between 
the dotted lines represents normal values. 
Mean plasma levels of calcium and phosphate were nomai up to 5 years 
after discharge (figures 2.6 and 2.7), while mean levels of magnesium were 
slightly decreased some two years after discharge from hospital (figure 2.8), 
calcium (mmol/l) 
26 
2 A 
2 2 
Figure 2.6 
Mean plasma calcium (± SEM) in course of time. 
n=number of patients at the time of investigation. The area between 
the dotted lines represents normal values. 
15 
phosphate (m mol/I ) 
1 5 т 
13 
1 1 
09 
Ч^ш ν 
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0 
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1 2 3 
Figure 2.7 
3 3 
ι 
2 3 
5 
year 
Mean plasma phosphate (± SEM) in course of time. 
n=nuinber of patients at the time of investigation. 
the dotted lines represents normal values. 
The area between 
magnesium (mmol/1) 
1 4 
12 
10 
0Θ -
-hH - * - / 
-*-клЛ 
н-*-*і 
n=7 8 6 6 3 3 2 3 
0 1 2 3 4 5 
year 
Figure 2.8 
Mean plasma magnesium (± SEM) in course of time. 
n=number of patients at the time of investigation. The area between 
the dotted lines represents normal values. 
Mean serum copper and zinc remained within normal limits (figures 2.9 
and 2.10). 
Serum cholesterol was permanently decreased after resection (figure 2.11). 
Plasma vitamin E levels fluctuated considerably (figure 2.12), while serum 
carotene levels were decreased sane two years after discharge and became 
16 
normal after that period (figure 2.13). 
copper [pmo\lI ) 
25 
20 
15 
10 
И+^ 
•n=4 5 6 5 4 4 4 3 2 3 
1 5 year 
Figure 2.9 
Mean serum copper (± SEM) in course of time. 
n=number of patients at the time of investigation. The area between 
the dotted lines represents normal values. 
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Figure 2.10 
Mean serum zinc (± SEM) in course of time. 
n=number of patients at the time of investigation. The area between 
the dotted lines represents normal values. 
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Figure 2.11 
Mean serum cholesterol (± SEM) in course of time. 
n=nuinber of patients at the time of investigation. The dotted line 
represents the lower limit of normal. 
vitammE [μτηοίϋ ) 
25 
20 
15 
10 
'47 
-m = 6 5 5 2 4 3 3 
5 
year 
Figure 2.12 
Mean plasma vitamin E (± SEM) in course of time. 
n= number of patients at the time of investigation. The dotted line 
represents the lower limit of normal. 
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Figure 2.13 
Mean serum carotene (± SEM) in course of time. 
n=number of patients at the time of investigation. The dotted line 
represents the lower limit of normal. 
Mean 25 OHD.. levels were clearly depressed (10,6 ng/ml ± 8.9 SD, η 14.5-
37.0). Results of serum cholesterol and levels of fat-soluble vitamins 
reflect fat malabsorption which was present in nearly all patients (table 
2.2). 
Serum levels of water-soluble vitamins, measured during the first three 
months of 1983, were normal in all patients. 
The D-xylose test appeared to be a valuable, simple method for assessment 
of the small bowel remnant capacity to absorb monosaccharides. In patients 
with preserved ileum (А, В, С and G),xylose absorption improved considerably 
in the course of time (figure 2.14). In patients without ileum hardly any 
increase in xylose absorption was noted. 
Results of Schilling tests (figure 2.15) indicate that 15 to 20 cm of 
remaining ileum is sufficient to absorb vitamin B..- adequately. 
Table 2.2 summarizes results of balance studies and provides information 
on bowel movements and stool weight during the balance period. The N-balance 
was positive or in equilibrium in all patients except patient F. In this 
patient, the transition from combined parenteral and enteral nutrition to 
completely oral feeding had just been completed. 
19 
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Table 2.2 
RESULTS OF BALANCE STUDIES AN AVERAGE OF 30 MONTHS (RANGE 12-60 MONTHS) 
AFTER EXTENSIVE SMALL BOWEL RESECTION IN θ PATIENTS. 
All patients Patients with 
ileum 
Patients without 
ileum 
N (g/day) 
Fat (absorption %) 
Ca (mmol/day) 
Mg (mmol/day) 
Ρ (mmol/day) 
Bowel movements per day 
Faeces weight per day(g) 
0.1±0.6 (SD) 
74 ±18 
1.7±2.6 
-0.2±1.5 
-2.213.4 
2.411.0 
8001450 
0.110.7 (SD) 
82 ±17 
1.8+2.4 
0.310.9 
-4.0±3.4 
1.910.8 
6401490 
0.310.6 
59 ±7 
1.6±3.6 
-0.9±2.1 
0.7±4.5 
3.2±1.6 
1070±250 
D -xylose — 
(g/5h urine ) 
8 0 
Figure 2.14 
D-xylose absorption in course of time. Patients with 15 to 20 cm 
retained ileum are indicated with a solid line; those without any 
ileum with a dotted line. The horizontal dotted line represents the 
lower limit of normal. 
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Figure 2.15 
Vitamin B12-absorption in 4 patients with 15 to 20 cm retained ileum 
(А, В, С and G) . The dotted line represents the lower limit of normal. 
Probably this condition temporarily influenced N-metabolism. Fat absorption 
varied from 52 to 95% (mean 74%). Results in patients with retained ileum 
were obviously better than those in patients without ileum. The latter also 
showed more frequent bowel movements per day, and stool weight was higher. 
Balances of calcium, phosphate and magnesiun were about equilibrium. 
Hyperoxaluria (0.9-1.3 mmol/24 h; n<0.6) was present in 5 out of 8 
patients. Apart from dietary oxalate restriction, 4 patients received 2 g 
calcium carbonate orally per day in order to complexate excess soluble 
oxalate intraluminally. In 2 of these 4 patients urinary oxalate excretion 
became normal. In one patient (E) hyperoxaluria persisted to the same 
extent and in another (F) urinary oxalate excretion could not be evaluated. 
It is to be noted that none of the patients had shown clinical signs of 
urinary calculi since the resection. 
Except for slight osteoporosis in 3 patients, no signs of osteomalacia 
were found in a concurrently performed osteological study . 
2.4.1 Ps^chosocial_aspects_ 
Of the initial 8 patients, 7 are still alive. One patient (B) died 
untimely due to ruptured aortic aneurysm in August 1982. None of the 
21 
patients is socially restricted due to frequent diarrhoea (table 2.2). Three 
patients have retired because of age (D and H) or for non-SBS-related medical 
reasons (C). Only one (E) of the remaining four patients is physically no 
longer able to do his foimer job. A tendency to depression, probably 
related to slight dementia, has recently been observed in one patient (H). 
2.5 Discussion 
2.5.1 Lraigth_ajid_can£osition_of the remaining small bowel 
Survival is unusual if, in addition to the duodenum, less than 25 cm 
jejunum or ileum is left ~ . Not only the length but also the composition 
of the small bowel remnant is important. After an extensive resection 
hyperplasia of the remaining small bowel occurs, a phenomenon called 
intestinal adaptation . As a result of this adaptation, absorptive 
function increases in the bowel remnant. The adaptive response in an ileal 
remnant is considerably greater than in its jejunal counterpart. When the 
ileocoecal valve is retained, diarrhoea seems to be less of a problem than 
when this valve is lacking ' . Diarrhoea after extensive small bowel 
resection is significantly aggravated when an additional colectomy is per-
formed ' ~ . The colon is normally able to absorb some six litres of 
19 fluid a day . In SBS, a preserved colon is therefore of extraordinary 
importance. In end-jejunostcmies, very large losses of fluid and minerals 
with recurrent episodes of dehydration and renal insufficiency have been 
observed ' ~ . In this condition, frequent parenteral supply of water 
and minerals or even indefinite parenteral nutrition may be needed ' 
Regular oral administration of solutions containing glucose or glucose 
polymers together with Na en К salts may also be of value in these circum-
22 
stances . In the case of an extensive bowel resection complications increase 
in the following sequence: 
1 Predominantly proximal small bowel resection with duodeno- or jejunoileos-
tomy 
2 Predominantly distal small bowel resection with jejunoileostmy 
3 Jejunocolostomy 
4 End-jejunostomy 
The prognosis in children with SBS is more favourable than that in adults. 
Like the child itself, the remaining small bowel has the potential of linear 
growth, which does not take place in adults. Normal growth and development 
22 
in children on oral nutrition appears to be possible when only 15 to 20 
cm of small bowel is present ~ . 
2.5.2 №soiptive_capacj^ of_the_remaming_smn_bowel 
Comparing literature data on the absorptive capacity of the remaining 
small bowel is difficult due to interindividual differences in the extent 
and site of resection and the interval since resection. Absorption of 
ι 
glucose(using GTT) appeared to be normal in patients with 40 to 100 cm of 
retained small intestine 2 to 10 months after resection ' ' .We used 
the D-xylose test to measure absorption of monosaccharides in the small 
bowel remnant. When a relatively small part of ileum was preserved, a gradual 
increase of D-xylose absorption was observed in the course of time (figure 
2.14).This was not the case when no ileum at all was left. This finding 
again confirms the superiority of ileal versus jejunal remnants in terms 
of functional adaptation. 
Ileal resection limited to 1 m or less does not give rise to clinically 
relevant steatorrhoea . The more ileum is removed, the more faecal fat 
excretion increases . This applies only partly to jejunal resections 
In extensive distal small bowel resection a strong correlation exists 
between oral fat intake and degree of steatorrhoea ' .In extensive 
proximal small bowel resection, however, increased fat cmsunption is 
3Θ 
often followed by increased fat absorption . Seme investigators found 
increasing fat absorption after months to years in their SBS patients ' ' 
However, other groups could not confirm this finding ' ' -.Our data are 
in agreement with those fron literature: patients with a retained part 
of the ileum and the ileocoecal valve have better fat absorption than those 
who have no ileum left at all. 
The body does not store protein as it stores fat. Certain quantities 
of protein have to be ingested daily in order to maintain various 
metabolic functions. Absorption of oligopeptides and amino acids primarily 
takes place in the jejunum . A positive N balance has seldom been obtained 
in patients with less than 20 cm of small bowel ' ' ' ' These patients 
almost invariably died with signs of severe protein and calorie malnutrition 
θ 9 11 13 
' ' ' . When more than 20 cm of small bowel is retained, a positive N 
balance can be achieved after seme time ' ' ' ' .Except for patient F, 
our data ση N balance agree with those from literature. 
In view of its importance in bone metabolism, Ca balances are relatively 
23 
frequently determined in SBS. Pietz generally obtained negative results, 
which was subsequently confirmed ' ' and denied ' . In our patients, 
the mean Ca balance proved to be slightly positive, probably resulting 
from the rather high calcium intake (mean 29.1 mmol/day). Regarding the 
Mg balance in SBS, again conflicting results have been reported ' ' 
As with Ca, a relatively low dietary fat intake has a positive effect on 
34 the Mg balance . In our SBS patients acceptable Mg and Ρ balances were 
obtained. 
Absorption of vitamin B12 gradually decreases when increasing parts of 
39 the ileum are removed . However, vitamin B12 absorption doubled in patients 
after proximal small bowel resection . Additionally, vitamin B12 absorption 
increased in the course of time in rats after partial distal small bowel 
48 
resection . Data on our patients indicate that normal vitamin B12 
absorption is finally possible when only 15 to 20 cm of ileum is retained 
(figure 2.15). 
2.5.3 S£ecif ic metabolic 2.roblems_in short bowe^ syndrome 
2.5.3.1 Gallstones 
In the case of ileal disease or resection, bile may become lithogenic 
due to the reduced bile acid pool resulting from bile acid loss into the 
colon. Gallstones can frequently be found in patients with ileal disease 
or resection ' ' ~ . In three of our patients (А, В and D) gallstones 
were detected, without causing symptoms. Especially in these patients, a 
reserved attitude concerning surgical treatment of silent gallstones is 
52 
warranted . 
2.5.3.2 Urolithiasis 
In chronic inflaimatory bowel disease, especially when ileal resection 
has taken place, the incidence of urolithiasis is increased " -.Hyper­
oxaluria is positively related to ileal resection ~ -,and is caused by 
57 increased oxalate absorption . Oxalate absorption from luminal contents 
mainly occurs via diffusion, especially in the colon . Normally, calciun 
binds oxalate in traluminally, forming insoluble calcium oxalate. TVo 
theories are available to explain small bowel resection-related hyperoxaluria: 
J_ Solubility theory 
When fat malabsorption is present, calcium in the intestinal lumen may 
bind with excess fatty acids, forming soaps. Oxalate solubility, absorption 
24 
and urinary excretion are subsequently increased. A correlation has been 
57 59 
established between the degree of fat malabsorption and hyperoxaluria ' 
After dietary fat restriction, a decreasedoxalate excretion has been 
, ,62,63 
observed 
2 Permeability theory 
Colonic permeability to oxalate increases in the presence of excess fatty 
64 
acids and bile salts . Both mechanisms are probably involved in SBS-
related hyperoxaluria. It has to be emphasized that other factors such 
as urinary volume, pH, Na and К content are of additional importance 
for the actual development of urinary calculi . Hyperoxaluria may be 
56 62 63 
managed by dietary reduction of fat and high-oxalate foods ' ' , and 
oral calcium suppletion . In at least two of four hyperoxaluric SBS-
patients, urinary oxalate excretion normalized with such treatment. 
2.6 Management of_short_bowel_sjrndrane 
As a result of gradual intestinal adaptation, the clinical course of the 
SBS shows three stages. 
1^  Postoperative period. 
In this stage, characterized by massive diarrhoea, parenteral nutrition is 
often necessary in order to maintain nutritional status and to prevent 
mineral and trace element losses. With restored continuity of the bowel and 
in the absence of intra-abdominal sepsis, oral feeding can be resumed very 
cautiously while parenteral nutrition still continues. 
II Transition fron parenteral nutrition to oral feeding. 
The presence of luminal nutrients and thus enteral nutrition is a prerequisite 
for the development of intestinal adaptation. There are conflicting opinions 
regarding the ideal composition of oral nutrition in this stage. Elementary 
diets, containing very small amounts of fat or fat replaced almost entirely 
13 67—69 
by medium-chain triglycerides (MCT), have acquired considerable support ' 
These diets are thought to be ideal since little digestion is required, 
facilitating absorption. However, absorption of various nutrients from a 
blenderized regular diet in SBS occurred to the same extent as absorption 
20 
of the same nutrients from various elementary diets . Furthermore, prolonged 
administration of elementary diets to animals caused mucosal hypoplasia in the 
the ileum . Finally, ordinary fat (long-chain trigylcerides) exerts a greater 
influence on intestinal adaptation than MCT, carbohydrates or protein . 
Altogether, there is hardly any place for MCT or elementary diets in the 25 
management of SBS. When tube feeding is indicated, a liquid formula 
containing as few predigested nutrients as possible has to be given. 
In this stage, frequent small meals (6 to 8/day) will help to utilize 
optimally the absorptive capacity of the small bowel remnant. Dietary fat 
reduction (40 to 50 g/day) is indicated in order to reduce stool volume and 
34 72 
minimize faecal calcium and magnesium losses '' . Dietary lactose 
restriction , or lactase suppletion of milk products , makes sense since 
the amount of lactase in the normal small bowel is only marginal. In SBS, 
therefore, lactose deficiency very easily occurs, resulting in osmotic 
diarrhoea. The size of the meals must be very gradually increased while 
titrating against stool production. In this situation loperamide or codeine 
phosphate may be of help. When the amount of tolerated orally administered 
food reaches some 2000 Kcal, patients can be gradually weaned of parenteral 
nutrition. 
Stage II may last weeks to months. 
H I Oral feeding 
A relatively stable situation has been achieved regarding the capacity to 
consime relatively large quantities of calories and stool production. Out­
patient clinic follow-ups have to be made very frequently. Attention has 
to be given to body weight, serum albumin .haemoglobin, minerals, vitamins 
zinc and copper. Rarely suppletion of one of these substances may 
be indicated. Urinary oxalate excretion should be evaluated from time to 
time. Monthly parenteral vitamin B12 suppletion has to be given when less 
than 15 to 20 cm of ileum is retained. Dietary fat restriction is no 
longer necessary ' ,unlike lactose restriction or lactase suppletion 
of milk products. Relatively large quantities of these milk products 
are advised, supplying considerable amounts of calcium. When hyperoxaluria 
is established, high-oxalate foods have to be avoided and oral calcium 
carbonate (up to 3 g/day) may additionally be prescribed. 
To maintain equilibrium the average caloric intake remains relatively 
high (2540 Kcal/day in our patients). 
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3 INTESTINAL ADAPTATION 
3.1 Introduction 
In normal circumstances the absorption of carbohydrates and many minerals, 
water-soluble vitamins and trace elements is completed before chyme reaches 
the ileum. Absorption of protein,fat and fat-soluble vitamins also 
predominantly occurs in the jejunum, although some absorption of these 
nutrients also takes place in the ileum . Vitamin B12 and conjugated 
bile salts are almost exclusively absorbed in the ileum. In quantitative 
terms, the jejunum is the most important site of nutrient absorption. This 
functional distribution is reflected in mucosal morphology in that an 
aboral villus height gradient is present in the small bowel . Consequently, 
the number of cells per villus is larger in the jejunum than in the ileum. 
The small bowel has a large functional reserve. The ileum is very 
important in this respect. After extensive small bowel resection the 
absorptive capacity of the remaining bowel increases, a phenomenon called 
intestinal adaptation. Most scientific data pertaining to intestinal 
adaptation have been obtained in animal studies, especially in the rat. 
3.2 Morphological aspects of intestinal adaptation 
Intestinal adaptation is morphologically characterized by hyperplasia of 
the remaining small bowel mucosa. Due to the larger number of cells 
populating each villus, its height and consequently its absorptive surface 
5—θ 9—11 
increases . These events have also been established in man . In the 
adaptation of small bowel segments, crypt depth also increases .However, 
the number of villi remains constant . Compensatory growth of the small 
bowel after partial resection involves all layers of the bowel wall, but 
lengthening of the intestinal remnant generally does not occur ' ' 
Besides, the luminal diameter may increase ' . The size of isolated 
epithelial cells populating hyperplastic villi is equal to or even analler 
than that of normal enterocytes as a result of increased migration from 
crypts along the villi ' due to increased cellular proliferation in the 
16 
crypts . The intensity of the hyperplastic response is directly 17 proportional to the length of intestine resected . A resection of at least 
Z0% of the small intestine is required to provoke hyperplasia in the bowel 
12 17 1Θ 
remnant ' ' . A schematic impression of intestinal adaptation is presented 
in figure 3.1. The hyperplastic response in the ileum is much greater than 
32 
that in the jejunum, which is favourable for the functional reserve of 
the ileum ' ' ' ' ' . Adaptive changes are always maximal near the 
anastomosis, and taper off distally ' ' . After jejuno-ileal bypass, 
hyperplasia of the remaining ileum is considerably more marked than that 
19—22 
of its jejunal counterpart, in animals as well as in man . Apart from 
23—2fi 
jejunectomy, partial or total colectomy causes hyperplasia in the ileum 
27 On the other hand, ileal resection provokes colonic hyperplasia . 
3.3 Functional aspects of intestinal adaptation 
As often seen, changes in morphology are related to functional changes. 
Increased absorption has been established in small bowel reimants of 
animals15'28-31 and man10,11'32'33. The absorptive capacity of each 
individual epithelial cell does not increase ' , leaving villus surface 
enlargement as explanation for increased absorption. The activity of 
various mucosal enzymes, expressed per weight unit of DNA (in other words, 
5 15 19 per cell) generally does not increase and occasionally even decreases ' ' ' 
34-36 
3.3.1 Time_required for Jntest inal_ada£tat^cm to_deve 1 op 
In the rat, hyperplasia of the small bowel remnant has been noted 
8 37 
within 48 hours of resection and is complete after 7 to 12 days ' . In the 
38 dog this process probably takes about 1-2 months . In man it generally 
takes even longer. Our own experiences generally indicate a period of 
39 
several months to about 2 years . 
3.3.2 Mechanisms_of intestinal_ada£tation 
The principal factors promoting intestinal adaptation include: 
-luminal nutrition 
-hormones 
-pancreatico-biliary secretions 
3.3.2.1 Luminal nutrition 
A regular supply of nutrients is indispensable for maintenance of the 
normal villus structure. Hypoplasia of the small bowel mucosa develops 
when food is restricted, e.g. in total starvation, in hypophysectomy-
induced anorexia and during total parenteral nutrition " . Hypoplasia 
disappears after resumption of oral feeding ' . Hyperplasia of the small 
bowel irucosa can be induced by hyperphagia. This phenomenon has been 
33 
established during exposure to low environmental temperatures, in 
hyperthyroidism, in artificial hypothalamic damage and during lactation . 
After transposition of ileum and jejunum, hyperplasia is found in the 
proximally situated ileum and hypoplasia in the distally situated 
jejunum ' ' . Transposition of a segment of the colon between jejunum 
52 
and ileum induced hyperplasia in the transposed colonic segment . Hypoplasia 
can be found in excluded loops of small intestine, e.g. in jejuno-ileal 
bypass and in Thiry-Vella fistulae ' ' . Perfusion with an elementary 
diet in such an isolated bowel loop prevented mucosal hypoplasia 
Hyperplasia in the ileum does not follow jejunectomy when nutrition is 
44 
exclusively provided parenterally . Altogether, there is overwhelming 
evidence that luminal nutrition is important in maintaining small bowel 
structure and stimulating adaptive changes after intestinal resection. 
Various nutrients in the luminal contents are known to have a trophic 
effect on small bowel mucosa. Such an effect has been established for 
some mono- and oligosaccharides ~ , complete amino acid solutions 
58 
and seme isolated amino acids . Long-chain triglycerides are by far 
• л.- «.59 
superior in mis respect 
The mechanism by which luminal nutrition exerts its trophic effect on 
small bowel epithelium is not completely understood. Transport processes 
of nutrients into the cell are probably more important than metabolism of 
the nutrients by the mucosal cell itself . Direct contact between nutrients 
and mucosal surface has also been implicated as stimulating release of 
gastro-intestinal hormones and/or inducing other biochemical mechanisms. 
In this respect, the enzyme ornithine decarboxylase (ODC) probably plays 
an important role. ODC is the first and rate-limiting enzyme in polyamine 
synthesis. The polyamines contained in all karyotic cells, play a role in 
DNA, RNA en protein synthesis . Short-term increased tissue ODC activity 
and polyamine synthesis are associated with the onset of hyperplasia, as 
has been established in ileal remnants after jejunectony and in the ileum 
61 
of intact lactating rats . 
Apart fron luminal nutrition, other mechanisms have to be involved in 
the development of intestinal adaptation, as demonstrated by the following 
observations. The occurrence of hyperplasia in the proximal jejunum after 
56 5Θ 
intraileal instillation of dextrose and amino acid solutions in rats ' 
The absence of hypoplasia in excluded loops of small intestine during 
49 lactation and when an additional small bowel resection was carried 34 
out ~ . Furthermore, the increased proliferative activity observed in 
extraintest inaily transplanted ileal mucosa after partial small bowel 
65 
resection is at odds with the luminal nutrition theory 
3.3.2.2 Hormones 
It has been firmly established that gastrin and prolactin do not play 
66—69 
a significant role in the adaptive processes . Other, as yet unidentified 
anterior pituitary and/or hypothalamic hormones may exert some influence in 
this respect ' ' .Cholecystokinin and secretin have been regarded as 
important factors promoting hyperplasia. Combined intravenous administration 
to dogs given exclusively parenteral nutrition, prevented mucosal hypoplasia . 
Infusion of cholecystokinin octapeptide and secretin alone in parenterally 
fed rats did not prevent hypoplasia71. It is not likely that these hormones 
have a significant trophic effect on gut structure. The effects observed 
in the dogs can be explained also by pancreatico-biliary secretions induced 
by these hormones. 
The most serious hormonal candidate promoting intestinal adaptation is 
enteroglucagon. An extraordinary clinical observation initiated research 
on enteroglucagon in this field: In 1971, a patient with an enteroglucagm-
producing tumour was described as showing marked intestinal hyperplasia and 
small bowel dilatation. After removal of the tumour, the gut structure and 
72 73 
the increased plasma enteroglucagon level became normal ' . Enteroglucagon 
is predominantly found in the ileum and colon. It is synthesized in specific 
mucosal endocrine cells, called EG cells . Its release is stimulated 
75 particularly by fat and carbohydrate . Increased plasma levels and tissue 
concentrations were found in the jejunum and especially in the ileum of 
rats made hyperplastic by hypothermia-induced hyperphagia . Increased 
ileal enteroglucagon contents were found also in intact 
lactating rats . Plasma enteroglucagon levels were significantly increased 
after jejunectomy . In similar experiments a higher crypt cell proliferation 
77 
rate was associated with increased plasma enteroglucagon levels . The 
latter were found also after ileal-duodenal transposition, in correlation 
with striking adaptive changes in the transposed segment which contained 
78 
more EG cells assessed on a weight basis . Increased baseline and 
postprandial plasma enteroglucagon levels were found also in patients with 
untreated coeliac disease, after jejuno-ileal bypass and distal small bowel 
79-81 
resection . In adequately treated coeliac patients the plasma 
35 
79 
enteroglucagm response was normal . In ileostomy patients the baseline 
plasma enteroglucagon level was low, but the postprandial rise was similar 
Θ2 
to that in control subjects . This phenomenon has been explained as a 
of relative adaptive response by the small intestine after the loss of 
a 
,83 
Θ2 
to that in control subjects . This phenomenon has been explained as a sign 
nail 
82 
colonic cells containing enteroglucagon . In normally fed neonates a 
striking increase in plasma enteroglucagon was found within one week 
However, newborns maintained by intravenous dextrose without any oral 
83 
nutrition showed no increase in plasma enteroglucagon . During long-tern 
exclusively parenteral nutrition in adults, the baseline plasma 
enteroglucagon level remained normal. Shortly after resumption of oral 
feeding a significantly increased postprandial plasma enteroglucagon level 
84 
was found . A correlation between enteroglucagon level and intestinal 
adaptation seems evident. However, increased plasma and/or tissue levels 
of this hormone occurred only in the presence of luminal nutrients. 
3.3.2.3 Pancreatico-biliary secretions 
Local hyperplasia can be induced by diverting the main biliary and 
OC Q7 
pancreatic duct to the ileum or to self-emptying loops of ileum . 
Ileal hyperplasia induced by jejunectomy can be further increased by 
88 
pancreatico-biliary diversion to the mid-point of the intestinal remnant . 
Whether bile or pancreatic juice is the most potent hyperplasia-promoting 
85 89 
factor cannot be definitively stated ' . Recent studies cast seme doubt 
on the pancreatico-biliary secretions theory. After transposition of the 
jejunun between stomach and duodenum, not only ileal hyperplasia was found 
but also hyperplasia in the jejunum (deprived of pancreatico-biliary 
secretions). Similar observations were made after identical surgery in 
parenterally fed rats, where hypoplasia was in fact expected90. The latter 
observation can only be explained as a result of humoral influences. 
Neurovascular and other mechanisms probably exert no significant 
91 influences on intestinal adaptation . 
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Figure 3.1 
A schematic impression of normal (A) and hyperplastic (B) 
villi and crypts of the small bowel. 
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4 METABOLIC BONE DISEASE AND SHORT BOWEL SYNDROME 
4.1 Introduction 
Short bowel syndrome (SBS) can be defined as a complex of symptoms and 
metabolic disturbances occurring when at least 701 of the small intestine 
is removed . Malabsorption of various nutrients is common in patients with 
SBS ~ . After some time, absorption in the small bowel remnant generally 
increases due to intestinal adaptation . Nevertheless, prolonged calcium 
and/or vitamin D malabsorption may cause osteoporosis and/or osteomalacia 
in this condition. Diminished enterohepatic circulation of 25-hydroxyvitamin 
D (25 OHD), the most abundant form of vitamin D in the circulation, may 
further compromise the vitamin D status . Chronic acidosis may cause 
7 θ 
hypercalciuria and subsequently osteoporosis ' . Not only calcium 
absorption, but also phosphate and probably magnesium absorption is 
9 10 influenced by vitamin D ' 
The occurrence of metabolic bone disease in small bowel disorders has 
been frequently reported. Especially in celiac and Crohn's disease, bone 
abnonmalities and signs of vitamin D deficiency have been noted 
In most reports dealing with bone metabolism and SBS, Crohn's disease 
16—22 
was the principal cause of extensive small bowel resection . Calcium 
malabsorption21'22, reduced 25 OHD levels 1 8' 2 0, vitamin D malabsorption18'20 
17 19 
and osteomalacia in some 25 to 36'» of these patients have been documented ' 
Recently, increased fecal loss of 25 OHD probably due to interrupted 25 OHD 
enterohepatic circulation has been established in these patients ' . 
Ill-defined, sometimes disabling bone diseases have been reported in 
patients on long-term parenteral nutrition for chronic intestinal disease, 
including SBS 2 5" 2 8. 
We studied 9 short bowel patients with a mean small intestinal remnant 
beyond the ligament of Treitz of 52 cm (range 0 to 110 cm). Two patients 
were dependent on parenteral nutrition, while the others took their food 
orally. No residual disease was present in the bowel remnants of these 
patients. We tried to find answers to the following questions: 1) Is 
metabolic bone disease present in short bowel patients on oral nutrition 
without residual bowel disease?, 2) Are parameters on bone metabolism 
abnormal in these patients? Assessed parameters include serum levels of 
47 
calcium, phosphate, magnesium and 25 OHD, absorption of Ca and balance 
44 
studies of calcium, phosphate, magnesium and fat. 3) is there any relation 
between these parameters and bone structure? 4) Is metabolic bone disease 
present in patients on long-term parenteral nutrition? 
4.2 Patients and methods 
4.2.1 Patients_ 
Nine patients age 31 to 75 years (mean 55.8 years) were studied an 
average 35.3 months (range 12 to 60 months) after extensive intestinal 
resection. Patients were divided into an oral group (7 patients) who 
maintained themselves on oral nutrition and two patients depending on 
parenteral nutrition (PN patients). Seme clinical features of the patients 
are listed in figure 4.1. 
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Figure 4.1 
Diagrams of the bowel composition of 9 SBS patjents. The upper part of 
each diagram represents the small bowel,the lower part indicates the 
large bowel.Anatamcal segments are separated from each other by dotted 
lines and indicated by abbrevations (Du=duodenum; J=jejunum; I=ileum,· 
Ä=ascending colon; T=transverse colon; De=descending colon,- S=sigmoid; 
R=rectum). The removed parts of the bowel are hatched. The amount of 
remaining small bowel is indicated in cm.Some other clinical data on 
the patients are added. 
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The length of the remaining small bowel was estimated fron measurements 
during laparotomy and by postoperative small bowel series. These methods 
29 
are assumed to be reliable in the case of SBS . No residual disease was 
detected on small bowel series and barium enemas. 
The two PN patients had been on home parenteral nutrition for 5 and 3 
years because of duodenotransversostomy. The parenteral nutrition scheme 
included 80 g amino acids, 300 g dextrose and 50 g lipid providing 2070 
kCal/day. Each patient daily received 110 mmol Na, 100 mmol К, 15 mmol Ca, 
15 rmol Mg, 20 mmol P, 160 irniol Cl, 25 mmol acetate and 60 mmol gluconate. 
D 
In addition, one vial daily of Vitalipid containing 120 IU vitamin D7, R 2500 IU vitamin A and 0.15 mg К and one vial of Soluvit-N containing 3 mg 
thiamine, 5 mg ribloflavin, 40 mg niacinamide, 5 mg pyridoxine, 16.5 mg 
pantothenic acid,400 yg folic acid, 60 yg biotin, 5 \ig vitamin B12 and 113 
mg vitamin С werd administered. Trace element solutions were prepared by 
the hospital pharmacy. Every day, 3.0 mg Zn, 1.6 mg Cu, 2.0 mg Mn, 120 yg 
Se, 2 yg Cr, 20 yg Co and 120 yg I were infused. 
One of the two PN patients (8) regularly consumed meals, while the 
other one (9) only took minor amounts of food. None of the patients of 
the oral group received vitamin D therapy, calcium suppletion or other 
drugs interfering with vitamin D or calcium metabolism during at least one 
year before and at the time of the study. The only dietary restrictions in 
the oral group concerned fat and lactose. All patients had normal 
creatinine clearance. 
The study was approved by the Committee on Human Ethics of this hospital. 
Informed consent was given by all participants. 
4.2.2 Experomental design_ 
The investigations were carried out during a ten-day stay in the 
hospital. All patients consumed a self-selected, fixed diet to which they 
were accustomed at hone. The meals of each patient were prepared in 
multiplícate, including one for analysis. During a three-day adjustment 
period urinary hydroxyproline excretion and plasma or serum levels of 
albumin, Ca, Ρ, Mg, alkaline phosphatase and bicarbonate were measured. 
Furthermore, the renal threshold for phosphate reabsorption (TMp-./GFR) 
was determined for detection of hyperparathyroidism. 25 OUD., levels in the 
oral group and 25 0HD7 levels in the PN patients were arbitrarily taken 
30 from winter 1980 because of its seasonal fluctuations 
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After the adjustment period balance studies lasting 5 days were carried 
out. The nutrients assessed were Ca, Ρ, Mg and fat. Carmine red served as 
fecal marker for stool collection in all balances. Finally, an iliac crest 
47 bone biopsy was taken and subsequently a Ca absorption study was performed. 
The experiments took place between December 1979 and June 1982. 
4.2.3 Biochemistry 
Serum albumin was measured by the bromcresol green method . Ca and Mg 
in plasma and in balance materials (diets, PN solutions, urine and stools) 
were measured by atonic absorption spectrometry. Plasma calcium was corrected 
32 in the case of hypalbuminemia . Phosphate in the abovementioned substances 
was determined by the vanadomolybdate method . Fat in diets was calculated 
by a dietician. Fat in stools was measured according to Van de Kamer . 
Alkaline phosphatase activity was determined by the 2-amino-2-methyl buffer 
35 36 
method and venous bicarbonate by a continuous flow CCL-procedure 
Hydroxyproline in urine was measured by a continuous flow modification of 
37 30 
Prockop's method . TM^./GFR was calculated according to Bijvoet . High 
performance liquid chronatography was used to determine 25 OHD . 
47 
4.2.4 Ca absorption 
—47 — 47 
To calculate Ca absorption a modified oral Ca retention study was 
used . After a breakfast subjects orally received 10 yCi Ca in 150 ml 
47 
milk containing some 175 mg calcium. The retention of Ca was determined 
by means of a shadow-shield whole-body counter, twice within 3 hours after 
administration of the isotope, and again after one, two and three weeks. 
A curve-fit was made from the latter three data, assuming mono-exponential 
47 
elimination fron the body of the absorbed Ca in this period. Corrections 
were made for physical decay of the isotope and background activity. 
47 
Retention at time zero (oral Ca administration) was extrapolated from 
this curve and assumed to be equal to apparent absorption. 
4.2.5 Bone_his tolo¿y_and_his tomorphometry 
Bone biopsy specimens were taken 2 cm posterior to the anterior superior 
iliac crest using a 4 ran internal diameter drill trephine according to 
Burckhardt . After dehydration the specimens were embedded in a 
methylmetacrylate mixture (UUA). Histology was interpreted by the 
histologist. Undecalcified 5 pm thick sections were made using 
47 
a Yung 1140 microtome. Sections were stained with Goldner. Using a grid 
consisting of a succession of semicircles, the following histomorphometric 
parameters were measured according to Schenk . 
osi: the percentage of the circumference line of the bone trabeculae in the 
section covered with osteoid. 
obi: the percentage of the circumference line of the bone trabeculae in the 
section covered with cubic (active) osteoblasts. 
oc%: the percentage of the circumference line of the bone trabeculae in the 
section covered with osteoclasts. 
h H : the percentage of the circumference line of the bone trabeculae in the 
section covered with Howship's lacunae. 
4.2.6 Statistical methods 
For statistical analysis Wilcoxon's two-sample test was used. Correlation 
coefficients were calculated according to Pearson. 
4.3 Results 
4.3.1 Вiochemistry 
In two patients (nos.S and 9) hypalbuminemia was present (29 and 25 g/1, 
respectively, n>37). In the other patients serum albumin was normal. None 
of the patients from the oral group had abnormal Ca, Ρ or Mg levels (table 
4.1). Two patients from the oral group (поь4 and 5) had increased serum 
alkaline phosphatase activity (180 U/l both; n<120) and increased γ-GT 
(60 and 70 U/l, respectively; n<36) and serum transaminases (1.4-2.2 times 
the upper limit of normal), suggesting liver disease. Bicarbonate was normal 
in the oral group but slightly decreased in the FN patients. 25 OHD levels 
were clearly diminished in both groups. Normal IMp^/GFR results were 
obtained, and hydroxyproline excretion in the urine was normal. 
47 
4.3.2 Ca absorption 
47 47 
Figure 4.2 shows the results of Ca retention and the calculated Ca 
absorption. The absorption of Ca (normally 27.3I±6.3 SD) was significantly 
reduced in oral group (16.0I±7.7 SD, p<0.05). Very low values were obtained 
in the two PN patients (5.0 and 3.1*»). 
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Table 4.1 
BIOCHEMICAL DATA ON 9 SBS PATIENTS AN AVERAGE 35.3 MONTHS AFTER EXTENSIVE 
INTESTINAL RESECTION. 
Serum or plasma level 
albumin 
calcium 
phosphate 
magnesium 
( g / D 
(mmol/1) 
(mmol/l) 
(mmol/1) 
a l k a l i n e p h o s p h a t a s e ( u / D 
v e n o u s b i c a r b o n a t e ( m m o l / 1 ) 
25 OHD (ng/ml)* 
TM ./GFR (mmol/1) 
P04 
u r i n a r y h y d r o x y p r o l i n e 
(ішпо1/24Ь) 
Oral 
mean 
39 
2.37 
0.93 
0.Θ1 
104 
25.2 
6.4 
0.85 
209 
group 
SD 
3.2 
0.11 
0.09 
0.11 
53 
2.1 
3.3 
0.09 
50 
PN patients 
θ 
37 
2.20 
0.98 
0-72 
120 
20.9 
5.9 
0.82 
189 
9 
25 
2.40 
1.27 
0.79 
67 
20.1 
4.9 
0.99 
146 
Normal 
>37 
2.20-2.55 
0.80-1.30 
0.70-1.25 
<120 
24.0-28.0 
10.0-24.0 
0.80-1.30 
<250 
* 25 OHD i n t h e o r a l g r o u p 
25 OHD i n t h e PN p a t i e n t s 
w h o l e body retention 
( % d o s e ) 
40 
3 0 
2 0 -
10-
Δ patient 8 
о patient 9 
47, 
Figure 4.2 
Graphic representation of mean values (±SD) of ^'Ca whole body 
retention in 7 SBS patients on oral nutrition.The hatched area 
represents values of ^Ca retention in 7 normal controls of 
comparable age as the 7 SBS patients.Results in 2 SBS patients 
on parenteral nutrition (8 and 9) are added.Apparent absorption at 
time zero is calculated with a curve-fitting procedure(indicated 
by dotted lines). 
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4.3.3 Balance studi.es 
In figure 4.3 the results of the Ca, Ρ and Mg balances are graphically 
presented. 
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Figure 4.3 
Results of balances of calcium, phosphate and magnesium, expressed 
as mmol/day. Mean values (±SD) are presented from the oral group; 
in the PN patients results are indicated individually. The lower bar 
represents mean balances(±SD) in the oral group while in the PN 
patients each balance is indicated individually. 
The average calcium content of the balance diets in the oral group proved 
to be rather high (29.1 mmol/day). This was mainly due to abundant 
consumption of cheese and lactose-free milk products. Mean phosphate 
intake also was relatively high (34.9 imol/day) in this group, while 
magnesium intake was normal (14.4 rano1/day). 
Calcium balance in the oral group ranged from -2.5 to +4.2 imol/day 
(mean + 1.1). The PN patients both had a slightly negative calcium balance 
50 
ol/day 
oral group 
Ca Ρ M g 
Ί 
P N patients 
• - C a - ι Ρ 1 — M g -
pat 8 9 θ 9 8 9 
^^ 
• oral intake p u r i n e 
0 parenteral intake D feces 
• balance 
C-I.6 and -3.2 imol/day). In the PN patients the daily fecal calcium output 
exceeded the oral intake by 6 to 7 mmols. Phosphate balance in the oral 
group was slightly negative (-1.5 mmol/day) while magnesium balance was 
almost in equilibrium in these patients (-0.2 mmol/day). The latter two 
balances were positive or in equilibrium in both PN patients. Not 
unexpectedly, a markedly decreased fat absorption (42 and 331) was found 
in the PN patients despite a low oral fat intake (57 and 15 g/day). Fat 
consumption in the oral group ranged from 50-114 g/day (mean 79). Fat 
absorption averaged 77% (± 17.2 SD). 
Apart from a significant correlation between phosphate content of the 
balance diets and phosphate balances (R=0.7666; p<0.05), no correlation 
was found between the other assessed balances and their related dietary 
constituents. No correlation was found between Ca absorption on the one 
47 hand and calcium and fat balances on the other, nor between Ca absorption 
and 25 OHD levels. Again no correlation was found between 25 OHD levels and 
calcium, phosphate and magnesium balances. 
4.3.4 Histology; and histomorjDhometry 
Slight osteoporosis was histologically found in three male patients of 
the oral group, the other 4 were normal. The mean age of the patients with 
osteoporosis was 63 years, whereas the non-osteoporotics averaged 53 years. 
Moderate and moderate-to-severe osteoporosis was found in both PN patients. 
In one patient (no 3) histomorphometric analysis could not be carried out 
due to unsuitable sectioning of the bone specimen. Histomorphometric data 
on the remaining 8 patients are presented in table 4.2. Normal values of 
age-matched controls according to Schenk are added. Generally, normal 
indices for bone foimation (os0s and oM) and bone resorption (oc$ and hH) 
were obtained in the oral group as well as in the PN patients. In one 
patient of the oral group (4) oc°s was increased, but biochemical signs of 
hyperparathyroidism were absent (normal plasma calcium and phosphate, normal 
TMpj-j./GFR and urinary hydroxyproline). When we correlated indices of bone 
formation and resorption on the one hand and the results of the Ca, Ρ and 
Mg balances and 25 OHD levels on the other, no statistical significance 
could be detected. 
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Table 4.2 
HISTOMORPHOMETRIC ANALYSIS IN PATIENTS WITH SBS 
Age Patient ло. os% ob% oc% hl% 
(years) 
31-40 8* 7.0 6.0 1.2 3.3 
normal(mean±SD) 11.6±5.9 5.0±3.3 0.5±0.5 6.3±2.5 
41-50 1 10.4 6.5 0.7 2.1 
2 4.6 0.9 0.4 1.9 
normal 13.1±4.8 3.8±0.9 0.6+0.7 7.5±4.3 
51-60 5 5.8 1.6 0.6 1.8 
6 11.2 6.4 1.6 2.3 
normal 17.1±9.1 5.2±4.7 0.5±0.4 6.1±2.7 
61-70 4 16.7 4.1 2.8 2.0 
9* 5.9 3.1 0 1.9 
normal 17.5±10.4 5.0±5.3 0.5±0.5 8.0±3.9 
71-80 7 15.3 2.6 0.7 2.5 
normal 20.5±14.3 3.5±3.6 0.6±0.4 5.8±2.9 
* Patients on parenteral nutrition. £or abbreviations see text. 
Normal values according to Schenk (each age category comprised 
16 to 32 controls). 
4.4 Discussion 
4.4.1 Oral_group 
The present study of the consequences of extensive small intestinal 
resection on calcium and bone metabolism differs from previous reports in 
that no residual bowel disease was present in our patients. This may be one 
of the reasons why normal data on bone formation and resorption were 
obtained, ruling out expected bone disease such as osteomalacia and 
secondary hyperparathyroidism. 
Slight osteoporosis was detected in three out of four patients above.. 
the age of 59. Whether this condition was already present prio' to the 
intestinal resection cannot be established. Calcium, phosphate and magnesium 
homeostasis appeared to be sufficiently maintained according to the results 
of the balance studies. 
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Although Ca absorption was reduced, mean calcium balance was positive 
(+1.1 mnol/day). Calcium balance remained positive when taking integumentary 
calcium loss (mean +0.4 mnol/day) into account. Generally, calcium 
absorption decreases with age and elderly persons require larger amounts 
of dietary calcium in order to maintain calcium balance, probably due to 
insufficient conversion of 25 OHD to the active vitamin D metabolite 
(1,25 dihydroxy vitamin D) ' . Therefore, it seems reasonable to advise 
a high oral calcium intake for SBS patients on oral nutrition. 
In addition, a phosphate-rich diet seems advisable in view of the positive 
correlation between phosphate content of the balance diets and phosphate 
balance. Special recommendations on magnesium are presumably not necessary 
since magnesium balance was in equilibrium on a normal oral magnesium 
intake. It has been previously shown that SBS patients generally do not 
17 
comply with dietary fat restriction, as we noticed in our patients . An 
extremely fat-restricted diet is therefore not warranted. 
Serum 25 CUD levels in these patients were rather low, suggesting vitamin 
AC 
D malnutrition . In view of the established positive calcium balance and 
the acceptable bone structure, routine suppletion of vitamin D is probably 
not necessary in SBS patients on oral nutrition up to 5 years after 
intestinal resection. 
4.4.2 PNjpatients 
Bone disorders have been reported in patients after at least two months 
of total parenteral nutrition by two independent groups25-28.Symptoms included 
periarticular lower extremity pain up to vertebral fractures which confined 
26 27 
sane patients to a wheelchair or even made them bedridden ' . There were 
no biochemical data to distinquish patients with symptomatic bone disease 
fron those without such symptoms . Hypercalcemia, hypercalciuria and 
negative calcium balances were often found. The Ш composition fron one 
center contained rather large amounts of phosphate (51 mmol/day) and 
vitamin D2 (1000 lU/day)2б'28. The other group administered 500 IU vitamin 
25 27 D2 daily or on alternate days ' . Normal levels of 25 CIHD2 were obtained 
27 2Θ 
from both groups, while 1,25 (OH) Dn levels were invariably reduced ' 
Histomorphometry revealed osteomalacia with or without prior signs of 
25 26 
increased bone turnover in addition to osteoporosis ' . Surprisingly, when 
vitamin D was removed from the Ш solutions or when parenteral nutrition 
was permanently stopped, symptoms abated gradually. Furthermore, calcium in 53 
serum and urine (if increased) became normal, negative calcium balance 
25 26 
reversed to positive and histomorphometiy improved considerably ' . Bone 
symptoms did not return in previously disabled patients after at least 
14 months of PN without vitamin D, while 25 OHD levels became very low or 
27 
indétectable . The cause of this remarkable syndrome remains uncertain. 
The main features in our two Ш patients are: a slightly negative 
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calcium balance, markedly depressed Ca absorption, hypercalciuria, 
slight metabolic acidosis, low 25 OHD, levels and the presence of moderate 
or moderate-to-severe osteoporosis. The absence of bone symptoms, osteomala­
cia and increased bone turnover is also notable, since PN lasted 5 and 3 
years in these patients. Hypercalciuria may be the result of the slight 
7 8 
metabolic acidosis (table 4.1) ' . The latter may be related to the 
administration of acidic aminoacid solutions . Intestinal absorption of 
calcium is not impaired by metabolic acidosis . Since fecal calcium output 
exceeded oral calcium intake by some 6 to 7 mmol, negative calcium balance 
was mainly based on net loss of calcium in stools (figure 4.3). Net loss of 
calcium in stools in amounts of 1 to 3 mmol/day has been reported in 
comparable PN patients without evidence of increased fecal calcium 
excretion of endogenous origin ' . After calcium infusion in short bowel 
patients with functioning colon, fecal calcium loss generally increases . 
The mechanism of intravenously administered calcium-induced increased fecal 
calcium loss has not been established. As with calcium there was a net loss 
of magnesium in stools in both IN patients, which also has been previously 
noted (figure 4.3). Phosphate intake and fecal phosphate excretion were 
in equilibrium in the PN patients. 
In conclusion, the following points can be made fron our observations: 
1 Having been left with 40 to 110 cm disease-free small bowel, patients 
appear to be able to maintain an acceptable balance of Ca, Ρ and Mg 
on oral nutrition, despite low 25 OHD levels. In addition, indices of 
bone formation and resorption remain within normal limits. A Ca- and P-
rich diet is advised in order to achieve this condition. 
2 Osteoporosis due to negative calcium balance threatens parenterally fed 
patients with an extremely short bowel, probably partly related to 
PN-induced slight metabolic acidosis. 
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5 IRON, ZINC AND COPPER BALANCE IN SHORT BOWEL PATIENTS ON ORAL NUTRITION 
5.1 Introduction 
Trace element research is currently receiving increased attention with 
the general recognition of the importance of these substances. Deficiencies 
of iron and iodine are well known. Since the advent of parenteral nutrition 
(PN), deficiencies have recently been established for an additional four 
to five trace elements (zinc, copper, chromium, selenium and probably 
1—8 
molybdenum) 
In patients with short bowel syndrome (SBS) nutrition is provided orally, 
parenterally or orally as well as parenterally, depending on the length 
and the absorptive capacity of the remaining small bowel. Generally, at 
least some 40 cm of jejunum and/or ileum have to be left in order to maintain 
Q 
an acceptable nutritional state on oral feeding . Nevertheless, malabsorption 
of various nutrients, including trace elements, and deficiencies may develop 
in orally fed SBS patients. 
When concurrently evaluating the status of a variety of trace elements, 
a balance study is generally performed " . In patients with SBS, some 
trace element balance studies have been carried out " . However, PN was 
the main or only route of delivering nutrients in these studies. 
This report discusses a balance study of three trace elements in seven 
SBS patients on oral nutrition. The assessed trace elements include iron, 
zinc and copper. 
5.2 Patients and methods 
5.2.1 Patients 
Seven patients, 6 males and 1 female, aged 18-68 years (mean 50.7 years), 
were studied an average 2.7 years (range 1 to 5 years) after extensive 
small intestinal resection. The short bowel remnant averaged 64 cm (range 
40 to 110 cm). Three patients had no or only 2 cm ileum left ; in one of 
these the ascending colon was also removed. None of the patients had 
radiological signs of residual bowel disease after the resection. The reason 
for the resections was: mesenteric infarction in five patients, strangulation-
induced obstruction ileus in one and small bowel necrosis due to volvulus in 
21 
one patient. All patients were on oral nutrition. Ideal body weight at the 
time of study varied from 85% to 116% (mean 931). No medication was used other 
than vitamin B12 suppletion in two patients. The study was approved by the 
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Committee on Human Ethics of this hospital. Informed consent was given by 
all participants. 
5.2.2 Exjerijnental_des ign and methods 
The balance studies were performed in hospital. Patients consumed a 
fixed diet according to their dietary habits at hone. The meals for each 
patient were prepared in multiplícate, including one for analysis. They 
were kept deep-frozen until consumption. To avoid trace element contamina-
tion during preparation of the meals, cooking was done in deionized water. 
In the kitchen all food was handled with knives, spoons, etc. after rinsing 
with deionized water. Meals were served and consumed using plastic dinner-
sets, first rinsed with deionized water. Tea and coffee were made with 
deionized water. 
After an equilibration period of three days the balance study was 
performed, lasting five days. At the start of the balance period, serum 
levels of iron, zinc and copper were measured. Serum iron was determined 
by ferrozine colorimetry, serum zinc and copper by atomic absorption 
spectometry. Additional precautions were taken to avoid trace element 
contamination during collection and processing of balance materials. Twenty-
four-urine and stools were collected in polyethylene bottles or containers 
washed in advance with an EDTA-detergent solution and subsequently rinsed 
several times with twice-distilled water.Stools collected during the 
balance period were marked with carmine red. Stools were homogenized with 
a mixer equipped with a knife of titanium (Moulinex, type MP2A, France). 
Homogenization of a 24-hour diet took place with a blender containing 
titanium knives (Waring Blender, Model 31 DL 44, USA). After weighing, 
aliquots were taken from collected urine, homogenized stools and 24-hour 
diet for analysis. During analysis of these specimens the abovementioned 
precautions to avoid contamination were maintained. 
Samples of balance materials were ashed in a low-temperatue asher and 
22 
subsequently measured by neutron activation analysis 
5.3 Results 
Mean serum levels of iron (18.4+3.7 pmol/l SD, η 10.0-25.0), zinc 
(11.4+1.5 ymol/1 SD, η 10.0-17.0) and copper (14.3+4.2 jjmol/l SD, η 10.0-
25.0) fell within normal limits. 
Mean daily oral intake, mean daily fecal and urinary excretion and mean 
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balance of the three trace elements are summarized in table 5.1. 
Table 5.1 
RESULTS OF BALANCE STUDIES OF THREE TRACE ELEMENTS (EXPRESSED AS pMOL/DAY) 
IN SEVEN SHORT BOWEL PATIENTS ON ORAL NUTRITION. 
Trace Recommended or Mean oral Mean fecal Mean urinary Mean 
element estimated appropriate intake excretion excretion balance 
daily dietary amount 2 6 (±SD) (±SD) (±SD) (±SD) 
Fe 
Zn 
Cu 
180 (males) 
320 (females) 
230 
32-47 
224.θ 
(73.1) 
173.9 
(28.7) 
25.4 
(16.8) 
196.2 
(63.0) 
154.2 
(24.5) 
22.1 
(14.1) 
0 
13.3 
(6.2) 
1.7 
(0.7) 
+28.6 
(10.6) 
+5.4 
(6.5) 
+ 1.5 
(2.3) 
In addition, recommended or estimated appropriate daily dietary amounts of 
each of the assessed trace elements are indicated. The mean balance of 
each trace element was positive. A negative Cu balance was only found once 
(-0.5 ymol/day). This patient, however, showed no signs of Cu deficiency 
such as anemia or leukopenia ' ' . Mean oral intake of Fe, Zn and Cu in 
these short bowel patients did not exceed recommended dietary amounts of 
these substances. Net absorption of Fe (dietary intake minus fecal 
excretion, expressed as percentage of dietary intake) averaged 12.6$ 
(± 1.8 SD). Mean net absorption of Zn was 9.39o (± 3.6Ό SD) and of Cu 12.SO 
(±5.1 SD). 
5.4 Discussion 
Balance studies have potential sources of error when inappropriately 
performed. Besides, a balance study does not provide information on true 
absorption, body distribution and turnover rate of the assessed nutrient. 
Moreover, extraintestinal and extrarenal losses are not dealt with. In 
the case of a trace element balance, additional precautions are required 
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to avoid contamination during collection and processing of balance 
materials. However, a carefully performed balance study is still of value 
to assess the nutritional response to disease or trauma, such as the short 
bowel syndrome24. 
When we compared the mean Fe balance in our patients with previously 
reported mean Fe balances in healthy controls, our results (+28.6 pmol/day) 
fell between those obtained from elderly men (65-74 years old) (-7.9 
Vimol/day) and those reported in generally younger persons (19-59 years 
12 15 
old) (+76 and +77 улюі/day) ' . Regarding net Fe absorption the same 
conclusion can be drawn: mean net Fe absorption in our patients (+12.6%) 
was higher than that in elderly men {-4.0%) and lower than in younger 
12 15 persons (+27.5 and +38.6%) ' . In none of the short bowel patients was 
any urinary Fe excretion found. Urinary Fe excretion in healthy controls 
is indeed very modest (not exceeding 1.8 μιηοΐ/day) ' ' . This result 
probably reflects maximal Fe retention in the SBS patients. 
The results of mean Zn balance in our patients (+5.4 щюі/day) fitted 
in the range of healthy controls mentioned in literature (-9.9 to +9.2 
ymol/day) ~ . Mean net Zn absorption in our patients (9.3%) was also 
comparable with data reported frem normals (range -3.6 to 9.2%) ~ . 
The results of mean Cu balance (+1.5 ymol/day) also fell in the range 
13—16 
obtained from normals (-2.5 to +7.0 ymol/day) . Mean net Cu absorption 
(12.5%) was higher than that in normals (-7.6 to +1.7%)13'14'16with one 
exception (+43.0%) 
Certain quantities of trace elements are lost daily in sweat. These 
losses are not included when performing a balance study. Measurement of 
trace element surface losses is technically difficult and subject to 
methodological problems. A recent study provides reproducible data on 
25 
whole body surface loss of trace elements in healthy controls . Mean 
daily Fe surface loss was 5.9 ymol/day. Daily, an average 7.6 ymol Zn and 
5.3 ymol Cu were collected in sweat. When these values are subtracted from 
our balance data, mean Fe balance remains positive (+22.7 ymol/day) while 
mean Zn and Cu balances become slightly negative (-2.2 ymol/day and -3.8 
ymol/day, respectively). 
In conclusion the following points can be made: 
1. In short bowel patients on oral nutrition with a disease-free, mean 
small bowel remnant of 64 cm (range 40 to 110 cm), Fe-, Zn- and Cu-
balance could be maintained in a similar way as in healthy controls. 
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2. Taking into account whole body surface losses of Fe, Zn and Cu, the 
balance of each of these trace elements remained acceptable in these 
patients. 
3. Net absorption of Fe and Zn in the short bowel patients is comparable 
to that in normal controls, but net absorption of Cu tended to be 
somewhat higher in short bowel patients than in healthy persons. 
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6 METABOLISM OF ORALLY ADMINISTERED 6 9 mZn IN PATIENTS WITH SHORT BOWEL 
SYNDROME AS COMPARED TO CONTROL SUBJECTS 
6.1 Introduction 
Zinc is an essential trace element because of its involvement in a 
variety of metabolic processes .. A role of zinc in nucleic acid and 
protein synthesis has been established " . Zinc deficiency is associated 
with retardation of growth and sexual maturation, poor wound healing, 
impaired imnune function and skin lesions mimicking those of acrodermatitis 
enteropathica ~ . Prolonged diminished oral intake or insufficient intra­
venous supply during total parenteral nutrition, malabsorption due to small 
intestinal disease and increased losses via urine or gastrointestinal 
fistulae may cause zinc deficiency ' Ί 0 - 1 ^ 
In short bowel syndrome (SBS) t defined as resection of at least 701 of 
the small intestine , malabsorption of various nutrients can be expected16. 
However, increased absorption in the anali bowel remnant of SBS patients 
occurs after some time when nutrition is orally provided . This intestinal 
adaptation is histologically characterized by hyperplasia of the remaining 
small bowel nucosa . 
To assess zinc metabolism in man, several methods are available. The 
increase in plasma zinc after a pharmacological dose of oral zinc has been 
used as a qualitative index of zinc absorption ' ~ . Another approach 
involves the use of radioisotope tracer techniques. In this respect, Zn 
has most frequently been used . The relatively long physical half-life 
of this radionuclide (245 days) limits its clinical usefulness. Sane recent 
reports suggest that the short-lived istope Zn is suitable to study 
27—30 
certain aspects of zinc metabolism 
The aim of this study was to evaluate some aspects of zinc metabolism 
after oral administration of Zn in patients with SBS and to compare the 
results obtained with those in normal controls. 
6.2 Patients and methods 
6.2.1 Patients 
Seven patients aged 40-74 years (mean 57 years) were studied an average 
of 2.6 years after extensive small bowel resection. Table 6.1 summarizes 
clinical and biochemical data on these patients, together with the results 
68 
Table б.1 
SOME CLINICAL AND BIOCHEMICAL DATA, TOGETHER WITH THE RESULTS OF ABSORPTION STUDIES OF FAT AND D-XYLOSE IN 7 
SBS PATIENTS. 
Patient Age at the Time since 
(male/female) time of resection 
study 
Small bowel % of ideal Serum Plasma 
remnant(cm) body weight albumin Zn 
l*(m) 
2*(m) 
3 (f) 
4 (m) 
5 (m) 
6 (m) 
7 (f) 
47 
60 
40 
68 
59 
55 
74 
(months) 
37 
38 
60 
45 
12 
12 
18 
jejui 
45 
100 
40 
50 
90 
20 
50 
(g/D (Umol/l) 
Fat D-xylose 
absorption absorption 
(%) (g/5 h portion) 
15 
10 
20 
0 
2 
20 
0 
96 
86 
115 
86 
86 
90 
72 
45 
40 
41 
39 
29 
40 
37 
12.9 
10.1 
12.9 
11.7 
9.3 
10.6 
16.2 
95 
91 
91 
52 
65 
82 
61 
4.8 
4.8 
5.2 
2.0 
3.1 
4.1 
2.1 
Range controls (mean) n=7 89-130 39-46 12.2-17.0 n.d. 
(104.5) (41.6) (14.0) 
n.d. 
Normal >37 10.0-17.0 >95 >5.0 
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•patient with normal Zn metabolism 
os n.d.= not determined 
ЧО 
of seme absorption tests. Strangulation-induced intestinal obstruction was 
the reason for resection in patient 3, and superior mesenteric artery infarc­
tion in the other patients. In two patients C4 and 7) a partial colectomy had 
to be performed as well. All patients consumed normal food products with 
only lactose restriction. None showed clinical signs of zinc deficiency. 
Decreased plasma zinc in patient 5 has to be related to the coexisting 
hyperalbuminaemia. Plasma zinc as well as serum albumin have permanently 
normalized in this patient three months after the study was performed. The 
healthy control group, without any previous abdominal surgery, consisted 
of 5 males and 2 females with a mean age of 52 years (table 6.1). The study 
was approved by the Committee of Human Ethics of this hospital. Informed 
consent was given by all participants. 
6.2.2 Stud^ design_ 
After an overnight fast each subject orally received 50 Ci Zn in zinc 
acetate (specific activity 1 Ci/mg Zn). Four hours after isotope ingestion 
breakfast was served. The radionuclide was measured in plasma, erythrocytes, 
whole body, stools, urine and over a fixed area of the liver and the lateral 
half of the left thigh. Red cell Zn was computed as the difference between 
whole blood Zn and plasma Zn, corrected for haematocrit. Plasma sampling 
was done i,1,2,3,4,5,6 and 10 hours after isotope ingestion and again after 
24 and 48 hours. Whole blood measuring took place 4 hours after Zn 
administration and subsequently at the same time intervals as plasma. Total 
body ^ n was measured several times on the day of Zn ingestion and 
daily for another 4 days. Measurements of Zn over the liver and thigh 
were performed hourly through 6 hours after its administration and again 
after one and two days. Twenty-four-hour stool and urine specimens were 
separately collected during 5 days. 
6.2.3 Isotope characteristics and measurements 
Zn decays with a physical half-life of 13.9 hours. It emits easily 
detectable photons at an energy of 439 KeV. Zn is produced by 
irradiating Zn (oxyde or metal) with thermal neutrons according to the 
reaction Zn (η,γ) Zn (Interuniversitary Reactor Institute, Delft, 
The Netherlands). The product is dissolved in HCl and purified by 
adsorbing on a small Dowex 2x8 cm column and eluting it with decreasing 
concentrations of HCl. Assuming 50^ absorption, the estimated whole body 
radiation dose from 50 \£i is 0.67 mSv (67 mrem) 
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^¿n in 3 ml specimens of plasma or whole blood was measured with a 
well-type Nal (Tl) scintillation crystal. Plasma ¿2n was expressed as 
percentage of the dose per litre and red cell Zn as percentage of the 
dose per litre red cells. Whole body Zn was determined with a shadow-
shield whole body counter with two 6x4 inch crystals, and expressed 
as percentage of administered dose. 
Activity over the liver and thigh was measured at fixed sites using a 
collimated 2x2 inch Nal (Tl) scintillation crystal (wide hole-equipped 
collijnator with aperture of 7 cm) with a skin-detector distance of 8 on. 
Counting time over the liver at least equalled the period needed to collect 
5000 counts and over the thigh at least the period to obtain 3 times 
background activity. As standard for liver and thigh served a bag containing 
1700 ml water to which Z% of the ingested isotope activity was added. 
Urine and stool specimens were determined between the two scintillation 
crystals of the whole body counter. Zn over liver and thigh and in 
stools and urine was expressed as percentage of dose administered. In all 
measurements corrections were made for physical decay and background 
activities. 
Apparent absorption of Zn was calculated fron data on whole body 
retention during 5 days, using a curve-fitting procedure according to 
Heth and Hoekstra32. 
6.2.4 Statistica^ metìiods 
For statistical analysis Wilcoxon's two-sample test was used. Data 
are presented as mean ± SEM. 
6.3 Results 
Analysis of the results of the SBS patients showed that ^¿n metabolism 
in two SBS patients (table 6.1, nos. 1 and 2) was largely comparable to that 
of the normal controls. The remaining 5 SBS patients showed a completely 
different Zn metabolism. Results will therefore be presented with regard 
to these observed differences. Results in controls and in the five SBS 
patients with abnormal Zn metabolism (abnonnal SBS subgroup) will be 
given as mean values. The data on the two SBS patients with noimal ^^n 
metabolism will be presented separately. 
Figure 6.1,showing curves of Zn in 
values were obtained 1 to 3 hours after isotope ingestion. Mean peak plasma 
n plasma, reveals that peak plasma 
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69m· 
'Zn in the controls was 2 to 2.5 times than that in the abnormal SBS subgroup. 
plasma 6 9 m Zn (%dose/1 plasma) — , 
controls I 
abnormal SBS subgroup 
patient 1 
patient 2 
χ p<005 
xx p<001 
Figure 6.1 
Curves of mean plasma 69mZn activity (± SEM) in controls and abnormal 
SBS subgroup.Individual curves of patients 1 and 2 are added. 
Significant differences between the two groups were found one, two and 
three hours after isotope administration. Red cell Zn gradually increased 
in SBS patients and controls, without showing significant differences 
between controls and the abnormal SBS subgroup except four hours after 
administration (table 6.2). 
69m, Zn 
Table 6.2 
RED CELL Zn (%/l red cells), 
Time 
4 
5 
10 
24 
4Θ 
(hr) C o n t r o l s 
0 . 2 9 ± 0 . 0 5 
0 . 3 2 ± 0 . 0 5 
0 . 3 6 ± 0 . 0 3 
0 . 4 9 ± 0 . 0 7 
0 . 7 3 ± 0 . 0 9 
Abnormal SBS sut 
0 . 1 6 ± 0 . 0 3 
0 . 2 2 ± 0 . 0 4 
0 . 3 U 0 . 0 9 
0 . 4 5 ± 0 . 1 1 
0 . 5 5 ± 0 . 1 2 
>group Ρ 
0 . 0 2 
η . s . 
η . s . 
η . s . 
η . s . 
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Cumulative urinary Zn excretion was very modest both in SBS patients 
and in controls, not reaching a significartdifference at any time. On day 5, 
emulative urinary Zn in the normal subjects was 0.571 (±0.14), in the 
abnormal SBS subgroup 0.20°4 (±0.08) and in SBS patients 1 and 2 0.09 and 
0.34%, respectively. 
The main excretory route of Zn was the faeces. Mean cumulative faecal Zn 
exceeded that in the control group (figure 6.2). 
cumulative faecal " 9 m 2 n excretion (%dose) 
100 
80 
60 -
АО 
20 
к 
-i-
I 
• controls 
— abnormal SBS subgroup 
— patient 1 
— patient 2 
χ p<0 02 
5 days 
Figure 6.2 
Mean cumulative faecal excretion of 69mzn (± SEM) in controls and 
abnormal SBS subgroup. Cumulative faecal 69mzn excretion in patient 
1 and 2 are indicated separately. 
Faecal isotope excretion in SBS patient 1 parallelled the mean curve in the 
controls. Remarkably, SBS patient 2 had no bowel movements on day 2 and 4, 
explaining the angular cumulative faecal Zn curve. 
Data on whole body Zn proved to be the mirror of cumulative faecal 
istope excretion (figure 6.3). Again significant differences were noted 
between controls and the abnormal SBS subgroup. 
Accurate calculation of apparent Zn absorption from whole body retention 
data appeared to be possible in 4 control subjects and in 4 patients of the 
abnormal SBS subgroup (figure 6.4). In the other subjects such calculation 
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was impossible due to insufficient data. The apparent ^*2n absorption 
in the controls was 46.5I±5.5 and that in the abnormal SBS subgroup was 
23.91+1.5 (p<0.05). 
whole body 6 9 n n Zn retention 
(V.dose) 
100 -, 
Θ0 
6 0 
АО 
2 0 
controls 
- - - abnormal SBS subgroup 
patient 1 
patient 2 
p < 0 02 
5 days 
eg Figure 6.3 
Mean whole body Zn a c i t i v i t y (± SEM) d e c l i n e in c o n t r o l s and 
abnormal SBS subgroup. Body 6 9nizn d e c l i n e in p a t i e n t s 1 and 2 i s 
shown in a d d i t i o n . 
whole body 69 m ^ n retention in patient 5 
(%dose) 
100 η о 
5 0 
10 
5 
1 1 1 1 г 
/ 5 1 2 3 4 5 
d a y s 
Figure 6.4 
An example of curve-fitting procedure to calculate apparent Zn 
absorption (Aa). 
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Activity of Zn over the liver was clearly higher in the controls 
than in the abnormal SBS subgroup, reaching significant differences from 
5 to 48 hours after isotope ingestion (figure 6.5). The curves of liver 
Zn in the SBS patients 1 and 2 were comparable to those in the controls. 
° Zn activity over the thigh equally increased in controls, abnormal 
SBS subgroup and SBS patients 1 and 2. However, the amount of accumulated 
Zn was small in this area of the body, not exceeding It of the ingested 
activity in any individual after 2 days. 
liver 6 9 n r i Zn 
controls 
abnormal SBS subgroup 
patient 1 
— patient 2 
χ p<002 
69m 
Figure 6.5 
Curves of mean liver ^~Zn activity (± SEM) in controls and 
abnormal SBS subgroup. Individual curves of patients 1 and 2 are 
added. 
6.4 Discussion 
At first sight it seems artificial to distinguish two subgroups of SBS 
patients after having obtained data cm Zn metabolism. When conparing 
clinical and biochemical data as well as absorption tests (table 6.1), there 
are clearly two subgroups. Why patient 3 did not show normal ^ 7 n metabolism 
is unclear because the abovementioned parameters in this patient were ccmpara-
ble to those in SBS patients 1 and 2 with largely normal Zn metabolism. 
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This study confirms that in normal persons oral administration of Zn 
induces a sharp rise in plasma activity, reaching a peak value between 1 
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and 3 hours, followed by a rapid decline (figure 6.1) ' .In the abnormal 
SBS subgroup mean peak plasma Zn was 2 to 2.5 times lower, suggesting 
impaired absorption and/or higher uptake in peripheral tissues. The latter 
statement is probably not valid in this subgroup since Ca) apparent Zn 
absorption is reduced to about half (23.9%±1.5) than in the control group 
(46.5I±5.5), (b) whole body Zn decline and cumulative faecal Zn 
excretion is significantly larger in the abnormal SBS subgroup than in the 
controls, (c) Zn accumulation in the liver in this subgroup is clearly 
reduced (figure 6.5) and (d) Zn uptake in red cells and thigh is equal 
to that in normal controls. 
These results may be understandable in view of the lower apparent 
absorption of ^¿n, which reflects dietary zinc absorption, in the abnormal 
SBS subgroup (241), as compared with that in the controls (46?o). The amount 
of albumin-bound (exchangeable) Zn in the plasma is about 2 mg. The absorbed 
amount of zinc is mudi larger (461 of 50 mg = 23 mg in the controls and 241 
of 50 mg = 12 mg in the abnormal SBS subgroup) than the intraplasmatic 
exchangeable zinc, causing the specific activity of plasma Zn to be 
approximately the same as that of the dose (0.92 vCi/mg in the controls). 
A decreased apparent absorption, as seen in the abnormal SBS subgroup, does 
not significantly change this situation (specific activity 0.86 yCi/mg). 
Thus, radioactivity can be used to compare the transport of Zn to the liver 
and the peripheral tissues in patients and controls. The peripheral tissues 
(e.g., muscle and red cells) have a constant need for Zn for incorporation 
in enzymes. They therefore take up a steady flow of Zn and the uptake of 
Zn was the same in patients as in controls. The liver not only needs some 
Zn for its own metabolism but apparently temporarily stores an excess of Zn 
when absorption is higher than the direct needs of the organism. Retention 
of zinc surplus has been shown in rats fed zinc-rich diets. In this situation 
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zinc accumulated amongst others in the liver . Because the absorption of Zn 
in the abnormal SBS subgroup is lower than that in the controls, the liver 
has to take up a smaller amount of excess Zn. This may explain why, although 
the absorption of Zn in the abnormal SBS subgroup is decreased, no clinical 
or biochemical signs of deficiency are observed an average of more than 2 
years after extensive small bowel resection. 
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A drawback of oral Zn is the impossibility to calculate apparent 
Zn absorption from whole body retention curves in each individual. This 
is due to the short physical half-life of the isotope. However, in the cases 
in which such calculation was possible our results in controls fell in the 
same range as values reported by others using Zn (range 43-74%) ~ . 
The main excretory route of Zn is the gastrointestinal tract. Notably, 
values of mean whole body Zn decline and mean cumulative Zn faecal 
excretion can be used interchangeably in normal subjects as well as in SBS 
patients (figures 6.2 and 6.3). 
In conclusion the following points can'be made: 
1 The maximum observed in the plasma Zn curve after an oral dose of 
this nuclide appears to be a reliable indicator of Zn absorption (figure 
6.1). 
2 In over 50°s of the controls and SBS patients, apparent Zn absorption 
can be calculated from whole body retention data. This retention can be 
measured either with a whole body counter or, since the urinary excretion 
is negligible, as difference between dose and cumulative faecal excretion. 
3 Extensive small bowel resection may lead to decreased Zn absorption to 
about half of that in controls. 
4 Because the flux of Zn to the peripheral tissues (red cells, thigh 
muscles) was adequate and signs of zinc deficiency were absent, the 
absorption of zinc in the abnormal SBS patients was presumably still 
sufficient. Apparently, the liver temporarily stores a smaller excess 
of absorbed zinc in these patients. 
5 The use of Zn is limited by its short physical half-life. Still, 
useful information can be obtained by measuring its appearance in 
faeces, plasma, red cells, liver and other parts of the body and its 
retention in the whole body, for further elucidation of zinc metabolism 
in various diseases. 
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7 HOME PARENTERAL NUTRITION. EXPERIENCE IN SEVEN PATIENTS. 
7.1 Introduction 
Tbe length of the small bowel in vivo roughly varies between 2 and 4 m . 
When 70Ό or more of the bowel is resected, a condition called short bowel 
2 
syndrome (SBS) results . Sufficient digestion and absorption of orally 
administered nutrients is generally ensured when, in addition to the 
duodenum, sane 40 to 50 cm of jejunum and/or ileum is retained. After more 
extensive small bowel resection, emaciation threatens due to severe 
malabsorption. 
In the late 1960's parenteral nutrition (FW) entered clinical medicine . 
FN is generally indicated when oral feeding is not possible or prohibited 
during long periods of time. In these situations, PN may prevent malnutrition 
or abolish already existing malnutrition. Usually, the time required to 
administer PN is relatively short. Indefinite PN may be necessary to sustain 
life in SBS patients with less than 40 cm of remaining small bowel.To avoid 
prolonged hospitalization, home parenteral nutrition (НШ) is to be preferred 
in this situation. 
In this paper we report experiences with HFN in seven patients, together 
with literature data cm the same subject. Patient selection, vascular 
access procedures and administration systems to deliver Ш solutions, 
technical and metabolic complications and some psychosocial aspects of HPN 
are emphasized. 
7.2 Case histories 
Patient A, a woman b o m in 1943,underwent extensive small bowel resection 
in February 1969 as a final consequence of an inadvertently performed 
urterine curettage for missed abortion. Tbe result was a uterus perforation. 
Some two-thirds of the duodenum and 20 cm of ileum remained in situ. One 
year later the body weight had fallen from 60 to 26 kg despite various dietary 
regimens. At that time, a Scribner shunt was constructed at an upper leg for 
administration of hypertonic PN solutions. As a consequence, body weight had 
increased to 44 kg 18 months later. In July 1971, a fatal arterial haemorrhage 
4 
occurred at home due to disruption of the tubing during PN infusion . In this 
patient a number of metabolic problems resulted from 18 months of HPN, such 
as chronic metabolic acidosis, hypercalciuria and osteoporosis, oxalate 
urolithiasis, linoleic acid deficiency and marked fatty liver. 
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In patient В, a woman bom in 1952, a duodenotransversostony was perfomed 
after intestinal resection for volvulus-induced small bowel and right colon 
necrosis in August 1976. At that time, she weighed 73 kg. PN was started 
shortly after resection via a venacaval catheter. Seme four weeks later the 
catheter was replaced by a bovine graft located in a forearm. Before 
discharge fron hospital the patient and her husband were given detailed 
instructions regarding the technique of graft puncture, administration of 
the PN solutions and the potential dangers related to Ш. All PN 
requirements, including solutions, additives, graft needles and administration 
systems are sent monthly to the patient's address by the hospital pharmacy. 
High fever accompanied with cold chills suddenly occurred during PN 
administration in May 1977. At admission (seme 12 hours later) patients was 
in shock (probably septic). A stormy clinical course followed, canplicated 
by diffuse intravascular coagulation, acute renal insufficiency and adult 
respiratory distress syndrome necessitating 3 weeks of artificial 
ventilation. Finally, ventilation tube-induced tracheomalacia had to be 
surgically corrected. In the meantime the bovine graft was thrombosed. A 
new graft was created in the other forearm. Discharge from hospital followed 
in July 1977. No problems have since developed. Table 7.1 sunmarizes 
clinical and biochemical data on patient B, together with those on patient 
С through G. Patient В visits the out-patient clinic every 8 weeks. She 
carries out her normal household duties. However, as compared with the 
situation before resection, her maximal exertional capacity has subjectively 
diminished to stane degree. 
Every evening her husband punctures the graft with a small-sized butterfly 
needle and subsequently attaches the needle to the FN administration system. 
Patient В as well as her husband have realistically adapted themselves to 
all PN-related inconveniences. 
Patient C, a woman bom in 1911, was likewise left with a duodenocolostomy 
because of thronbosis of the superior mesenteric artery in August 1977. Ш 
was started inmediately after resection via a venacaval catheter. Her body 
weight at that time was 69 kg. Two attempts to create an arteriovenous 
fistula unfortunately failed, and PN therefore had to be continued via a 
venacaval catheter. As in other patients, PN was infused during evening 
and night. Because the patient was living in a home for the aged, some 
nurses from this house were instructed in all aspects of PN. 
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00 Table 7.1 
CLINICAL DATA OF PATIENTS В THRCUGH G. BIOCHEMICAL DATA OF PATIENTS B, D, E AND G ARE FROM JUNE 1981, 
OF PATIENT В FROM AUGUST 1980 (TWO MONTHS BEFORE DEATH) AND OF PATIENT F FROM JANUARY 1981. 
Patients 
Sex 
Year of birth 
Length (m) 
Weight (kg) 
Indication HPN 
Vascular access 
PN since 
HPN since 
Plasma or serum levels (normal) 
-haemoglobin (7.8-10.0 mmol/l) 
-albumin (>37 g/1) 
-transferrin (2.0-4.0 g/1) 
-bilirubin ( 15 ymol/l) 
-alkaline phosphatase ( 120 U/l) 
-ASAT ( 25 U/l) 
-ALAT ( 25 U/l) 
-Ca (2.20-2.55 mmol/l) 
-P (0.80-1.30 mmol/l) 
-Mg (0.75-1.25 mmol/l) 
-Cu (10.0-25.0 mmol/l) 
-Zn (10.0-17.0 mmol/l) 
-vitamin B12 (225-600 pmol/1) 
-folic acid (10.0-35.0 nmol/1) 
-vitamin E (17.0-34.0 Pmol/l) 
f 
1950 
1.65 
64 
SBS 
bovine 
graft 
aug. 1976 
nov. 1976 
7.8 
36 
2.8 
12 
116 
21 
23 
2.19 
0.82 
0.71 
15.0 
10.1 
320 
10.0 
15.8 
f 
1911 
1.60 
66 
SBS 
vena cava 
catheter 
aug. 1976 
see text 
6.2 
25 
1.6 
15 
97 
21 
17 
2.47 
1.15 
1.10 
16.7 
14.5 
265 
9.4 
32.5 
m 
1963 
1.80 
64 
SBS 
bovine 
graft 
nov. 1979 
juli 1980 
8.5 
43 
2.4 
n.d. 
118 
15 
19 
2.29 
1.31 
0.77 
12.6 
11.4 
345 
13.9 
14.3 
f 
1940 
1.57 
49 
high output 
jejunostomy 
Cimino 
fistula 
okt. 
okt. 
8.0 
38 
n.d. 
n.d. 
115 
28 
13 
2.52 
0.74 
0.73 
18.5 
10.0 
510 
17.5 
11.4 
1980 
1980 
f 
1957 
1.71 
48 
intraabdom. 
malignancy 
vena cava 
catheter 
june 1980 
sept. 1980 
9.7 
31 
n.d. 
310 
244 
174 
138 
2.21 
1.48 
0.92 
35.0 
14.4 
n.d. 
n.d. 
n.d. 
m 
1916 
1.74 
70 
scleroderma 
small bowel 
bovine 
graft 
okt. 1980 
dec. 1980 
7.2 
36 
n.d. 
n.d. 
99 
19 
11 
2.41 
1.10 
0.81 
20.5 
10.6 
335 
20.5 
23.9 
n.d. = not determined 
In this patient a devastating number of technical and metabolic problems 
accumulated in the course of time. Catheter migration necessitating its 
removal occurred three times, and catheter sepsis even five times. 
Consequently, a congested face finally resulted from catheter-induced , 
obliterated veins in the infraclavicular,, supraclavicular and neck area. 
The longest catheter life-span was 9i months. Catheter complications 
frequently necessitated hospitalization. Altogether, during 38 months of 
Ш, this patient spent only 10 months in her nursing home. In the course 
of 1980 the situation deteriorated significantly. A trauma-induced 
vertebral fracture, further limiting the patient's mobility, periods of 
fever of unknown origin, mental depression, increasing dementia and finally 
unexplained prolonged episodes of disturbed consciousness led to a 
practically vegetative existence. Patient died in October 1980. 
The postmortem revealed adhesive pericarditis, myocardial hypertrophy 
and sclerosis of the coronary vessels. In addition, marked atherosclerosis 
was present elsewhere. The liver showed moderate fatty changes and 
haemosiderosis. Hypertrophic Kupffer cells containing many intracytoplasmic 
granulae were noted. These granulae are probably related to prolonged 
Intralipid administration5. Moderate-to-severe osteoporosis was also 
observed. 
The major metabolic problems in this PN patient included unexplained 
anaemia and hypalbuninaemia, and zinc deficiency. 
Volvulus-induced necrosis of the small bowel in November 1979 was the 
cause of SBS in patient D, a man bom in 1963. PN was started imediately 
after resection via a venacaval catheter. The clinical course was 
characterized by recurrent intra-abdominal sepsis, necessitating 
repetitive abscess drainage, etc. Patient was transferred to this 
hospital in January 1980. Massive diarrhoea was present in addition to 
abdominal colics and vomiting after ingestion of small amounts of food. 
Zinc deficiency developed with characteristic skin lesions. Small bowel 
series revealed stenosis in the small bowel remnant and some adjacent 
fistulae between various bowel segments. The stenotic and fistulacmtaining 
bowel segments were successfully removed. Finally, sane 50 cm of small 
bowel was retained, a part of which showed a peculiar X-ray pattern. 
Virtually no folds were left, probably due to disturbed venous outlet 
but intact arterial supply. A bovine graft was constructed in a forearm 
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and has been used for PN since June 1980. Two months after its construction 
thrombectomy has to be performed. No graft problems have since occurred. 
Patients was discharged frem hospital in June 1980. At heme, he proved able 
to manage himself completely in PN. 
From 1981 patient was taking large amounts of food in addition to the PN. 
The amount of nutrients taken intravenously was being gradually reduced. In 
July 1981 PN could be finished because at that time the functional capacity 
of the remnant bowel has increased sufficiently. 
Patient E, a weman bom in 1940, had suffered from Crohn's disease since 
1958. Many bowel resections including proctocolectomy had to be performed 
due to prolonged increased disease activity. By the end of 1979 only 1 m of 
jejunum was retained. The jejunostomy output proved to be invariably high 
(2-5 1/day), causing recurrent dehydration and renal insufficiency. In 
addition, hypocalcaemic and hypomagnesaemic tetany was frequently observed. 
Attempts at adequate compensation by oral suppletion failed. Daily parenteral 
suppletion of large amounts of fluid and minerals became necessary. Recurrent 
disease in the bowel remnant was excluded. In view of relatively poor oral 
food intake, amino acids and concentrated dextrose were also infused. For 
this reasons a venacaval catheter was introduced. After 2 months of Н Ш 
without trace element suppletion, zinc deficiency developed (serum zinc 
1.6 ymol/l, η 10.0-17.0) which could easily be managed by parenteral 
administration of zinc. Some months later catheter sepsis occurred. HPN has 
since taken place via a Cimino fistula previously created in a forearm. 
In January 1980 gastrectomy was perfomed for carcinoma of the stomach in 
a woman bom in 1957 (patient F). Since the tumour was not radically removed, 
additional abdominal radiotherapy was given (6000 Rad). Mechanical ileus in 
June 1980 prohibited oral feeding. PN was started at that time. Laparotomy 
in August 1980 revealed unresectable intra-abdaninal tumour growth, causing 
intestinal obstruction. Although she realized that the prognosis was poor, 
the patient positively indicated her desire to remain alive as long as 
possible while staying at home. To organize and learn all aspects of HPN, 
patient was admitted to this hospital in September 1980. In view of a modest 
life expectancy a venacaval catheter was used to administer PN. 
The first 4 months at heme were uneventful. She almost completely 
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succeeded in carrying out household activities. After these 4 months her 
physical condition gradually deteriorated. She became jaundiced and liver 
function progressively deteriorated, probably due to hepatic metastasis. 
She died in April 1981. Abdominal pain did not occur until the day of her 
death. 
Patient G, a man b o m in 1916, had had scleroderma since 1971. In 
subsequent years, the lungs and gastrointestinal tract became involved in 
the disease process. Persistent reflux oesophagitis was caused by a 
dilatated, rigid oesophagus. To relief heartburn patient excessively consuned 
milk and antacids, which occasionally caused hypercalcaemia. The small bowel 
became considerably dilatated, with signs of bacterial overgrowth. In 1980, 
anorexia and significant weight loss developed due to recurrent paralytic 
ileus. PN was started in October 1980 via a venacaval catheter, which had 
to be replaced twice because of catheter migration and sepsis. From May 
1981, Н Ш has been administered through a boven graft. 
7.3 Some aspects of prolonged parenteral nutrition at home. 
Scribner et al were the first to point out the feasibility of HPN . At 
present, the longest reported period of HPN is 90 months . In 1980, sane 
600 patients were depending on HPN in the USA, and sane 30 in England ' . 
A suimiary of literature data on НТО till 1981, together with our experiences, 
is presented in table 7.2. Obviously, this way of delivering nutrients 
relatively often entails technical, metabolic or psychosocial problems. 
7.3.1 Patient_selectiOTb 
A. The main indication for HPN is SBS. Causes of SBS include recurrent 
intestinal resection for Crohn's disease, volvulus-induced necrosis of the 
small bowel and thrcmbosis or embolism in the superior mesenteric artery. 
The incidence of mesenteric infarction gradually increases after age 40. 
This rise shows significant progressiveness after age 60. 
Exact information on the length, conposition and quality of the small 
bowel remnant is required to evaluate the indication for prolonged PN. When 
in addition to the duodenum 40 to 50 cm of small bowel is retained, 
equilibrium is generally achievable by oral feeding alone, due to intestinal 
adaption. After extensive small bowel resection, oral nutrition provokes 
hyperplasia and subsequently increased absorptive function of the remaining 
mucosa . For patients В and С Cboth were left with a duodeno-transversostomy 
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Table 7.2 
DATA FROM LITERATURE AND OWN EXPERIENCES ON TECHNICAL, METABOLIC AND 
Patients 
Number of patients 
Age 
Time on HPN (months) 
average 
Indication HPN 
-SBS 
-Crohn's disease 
-radiation enteritis 
Ivey e.a 
(1975) 
40 
4-71 yr 
n.m. 
11 
n.m. 
62 Shils б 3 
(1975) 
11 
n.m. 
n.m. 
θ 
9 
1 
Jeejeebhoy e 
(1976) 
12 
19-64 yr 
4-62 
24-3 
10 
.a.
64 
-intestinal pseudo- 1 
obstruction 
-coeliac disease 
-scleroderma small bowel 1 
-gastrointestinal fistulae 
-intraabdominal malignancy 
-other 1 
Average catheter survival n.m. n.m. 10.5 
(months) 
Catheter complications n.m. 
-sepsis 6 3 
-skin entry site infection 
-blockage 
-leakage 
-unacceptable migration 3 
-thrombosis vena subclavia 3 
or vena cava superior 
Metabolic complications n.m. 
-linoleic acid deficiency 3 
-Zn deficiency 
-Cu deficiency 
-Cr deficiency 1 
-liver function disturbances 1 1 
-metabolic bone disease 1 
Psychosocial aspects n.m. n.m. 
-recurrent mental depression 2 
-socially partly active 3 
-socially fully active 7 
n.m.= not mentioned 
n.a.= not applicable, since majority of patients ultimately received PN via 
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PSYCHOSOCIAL ASPECTS OF HOME PARENTERAL NUTRITION (HPN) . 
Rault e.a 
(1977) 
65 
Byrne e.a 
(1979) 
66 
Dudrick e.a. 
(1979) 
67 
Fleming e.a. 
(1980) 
This study 
51 
5-69 yr 
1-56 
12.9 
106 
2wk-77 yr 
li-60 
n.m. 
25 
2-66 yr 
36 
n.m. 
19 
27-67 yr 
3-90 
25.5 
18-69 yr 
5-53 
25 
20 
13 
5 
3 
1 
3 
1 
5 
8.8 
16 
43 
9 
2 
2 
4 
10 
22 
13 
4 
1 
1 
10 
4 
17 
13 
1Θ 
14 
6 
26 
7 
12 
arteriovenous fistulae (see text), 
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or -colostomy) life-long PN is indicated without any doubt. In borderline 
cases (patient D) a high caloric oral diet, only lactose-restricted, is 
recommended to promote intestinal adaptation. Additional PN may be needed 
during several months to maintain equilibrium. When optimal adaptation is 
not achieved, a decision to start life-long PN can still be made. 
In SBS a retained colon is enviable. It is capable to absorb daily some 
6 litres of fluid and electrolytes . In SBS, calcium absorption is positively 
12 
correlated with the presence of the colon . Furthermore, colonic hyperplasia 
has been observed in animals after distal small bowel resection . 
Consequently, problems due to excessive losses of fluid, minerals and 
trace elements may be expected after end-jejunostomy. Permanent PN at home 
may alleviate this situation , as demonstrated in patient E. 
The largest group of SBS patients for whom HPN may be of vital importance 
is probably that with mesenteric infarction. The question arises whether all 
these persons should be considered for HPN, because most of these patients 
are aged or very aged. Various factors determine the answer to this question, 
such as mental condition before and after resection, family structure, 
living circumstances, etc. No absolute rules can be given in such a 
situation. 
B. When the absorptive function of a non-resected small bowel is markedly 
compromised or practically nil, HPN may offer alternative help. Examples of 
this condition are severe radiation enteritis, intestinal pseudo-obstruction, 
scleroderma or amyloidosis of the small bowel and refractory coeliac 
disease (see patient G ) . 
С HPN for Crohn's disease has received special support in the USA. 
Reported indications for Crohn's disease are therapy-resistant prolonged 
increased disease activity, recurrent gastrointestinal fistulae despite 
frequent surgical therapy and growth retardation in children or 
15—Ifl 
adolescents . Providing "bowel rest" and subsequently reducing disease 
activity is the principle of treating Crohn's disease with PN. Once it is 
decided to administer PN in such patients, various factors determine 
whether this treatment is to be given in hospital or at home. One of these 
factors is the expected period of PN administration. No prospective studies 
are available indicating any superiority of prolonged PN (at least 2 
months) over conventional medical management in comparable groups of 
90 
patients. Furthermore, it is not clear whether PN effectively reduces the 
operation rate. 
D. Whether HPN is an acceptable treatment in patients with incurable 
intra-abdominal malignancies, depends on several factors. A discussion on 
this subject is beyond the purpose of this article. Nevertheless, even 
more cautious selection is required in these patients. 
7.3.2 Vascular_access injicme parenteral_nutrition 
Infusion of hypertonic PN solutions into peripheral veins invariably 
causes thrombophlebitis. Dudrick et al abolished this problem by 
introducing a catheter into the superior vena cava via the sublcavian 
vein. The large diameter of the superior cavai vein allows rapid dilution 
of the hypertonic PN solutions, avoiding damage to vein walls. By 
tunelling the catheter across the anterior chest before reaching the 
19 
subclavian vein, the incidence of ascending infections is reduced . 
Obviously, continuous meticulous catheter care is necessary to minimize 
20 
the risk of catheter sepsis . Initially a Scribner shunt was used for 
prolonged PN administration ' . In view of recurrent shunt clotting this 
21 
method has been abandoned . Another route of vascular access for HPN is 
via a subcutaneous arteriovenous fistula or a bovine graft. Preferably it 
should be placed in a forearm. The arterial blood flow widens the venous 
part of the arteriovenous fistulae, enabling easy puncture. The high blood 
flow in the fistula of graft ensures sufficient dilution of the ΓΗ 
solutions. In our opinion this method is to be preferred in HPH. This 
vascular access was successfully used in patients B, D, E and G. In 
patient B, for example, a bovine graft has been functioning for 4 years 
without any complication. This way of HPN administration has so far 
received little attention " . 
7.3.3 Acbnini£tration_s^stan 
One of the main principles of PN is to maintain constant flow rates 
during infusion in order to avoid dangerous variations in blood sugar and 
other side effects such as nausea and vomiting during rapid amino acid 
25 infusion . Electrical pumps or a pneumatic pressure system ensure constant 
flow rates during FN administration. A new development is the ingenious 
26 flow regulator which forms part of the Isoflux administration set . It 
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enables concanitant gravity drip infusion of several different sterilized 
PN solutions at a constant flow rate, making energy-requiring pump systems 
superfluous. 
7.3.4 TechnicajL ccmpHcations 
Technical complications are encountered in every HPN vascular access 
procedure. Important reasons for catheter replacement include catheter 
sepsis, blockage, etc. С table 7.2) .Thrombosis is the main arteriovenous 
fistula complication. 
Before discharge fron hospital, the patient and the nearest relative(s) 
have to be thoroughly instructed in all practical aspects of PN administration, 
e.g. catheter exit care, attachment and detachment of bags with PN solutions 
to the venacaval catheter or the needle in a subcutaneous fistula, etc. 
Furthermore, they have to acquire seme theoretical knowledge about PN in 
order to realize better the potential risks of this treatment. A printed 
manual describing all these aspects is therefore indispensable. Generally, 
most patients satisfactorily adhere to the protocol after longer periods of 
-·
 2 7 
time . 
7.3.5 Composietion of the £arenteral_nutrition_ 
The department of clinical pharmacy of this hospital prepares concentrated 
dextrose solutions to which various minerals are added. Trace element 
solutions are prepared as well. Conmercially available amino acid solutions, 
fat emulsions and water- and fat-soluble vitamins are used. 
Each patient adds trace elements and vitamins to dextrose-mineral 
solutions just before administration. At heme, PN infusion takes place 
during the evening and night. Table 7.3 shows the PN cemposition for patients 
B, C, F and G, who are completely dependent on PN. 
7.3.6 Metabolic ccmpHcations of jrolonged_parenteral nutrition 
In the earlier days of PN, various deficiencies developed rather 
frequently, mainly due to insufficient intravenous supply of the nutrients 
in question. Sometimes deficiencies were observed due to excessive losses, 
such as minerals and trace elements in upper gastrointestinal fistulae and 
high output end-jejunostomy. 
A. Clinical signs of linoleic acid deficiency (patient A) include dryness, 
28 thickening and desquamatici of the skin . Linoleic acid deficiency states 
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Table 7.3 
DAILY COMPOSITION OF PN OF PATIENTS B, C, F and G 
Glucose 15% 
Fat (Intralipid 10%) 
Amino acids (Aminoflex 8%) 
Minerals 
Na 
К 
Ca 
Mg 
Ρ 
Cl 
Trace elements 
Cu 
Zn 
Mn 
Se 
Cr 
Co 
J 
Vitamins 
-Fat soluble vitamins 
A (retinol) 
D (calciferol) 
κ1 
present in 
one vial 
Vitalipid 
E (tocoferol) present in 500 ml Intralipid 10% 
-Water soluble vitamins 
Bj (thiamin) 
B2 (riboflavin) 
niacinamid 
Be (pyridoxin) 
folic acid 
Bj2 (cyanocobalamin) 
pantothenic acid 
biotin 
С (ascorbinic acid) 
present in 
one vial 
Soluvit-N 
300 
50 
80 
80-110 
70-110 
15 
15 
20 
110-150 
1.6 
3.0 
2.0 
120 
2 
20 
120 
g 
g 
g 
mmol 
mmol 
mmol 
mmol 
mmol 
mmol 
mg 
mg 
mg 
Pg 
pg 
из 
vs 
0,75 
3 
0,15 
50 
3.09 
4.93 
40 
4.86 
0.4 
5 
16.5 
60 
ИЗ 
mg 
yg 
mg 
mg 
mg 
mg 
mg 
mg 
mg 
W 
mg 
ve 
mg 
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29-32 
were primarily seen in the USA , because the use of fat emulsions 
was only recently approved by the Food and Drug Administration. Biochemical 
signs of linoleic acid deficiency may arise within a few weeks of fat-free 
32 
PN . Skin abnormalities generally appear afterwards. Prevention of 
linoleic acid deficiency requires intravenous administration of at least 
1000 ml 101 Intralipid per week . Topical application of linoleic acid 
may enable healing of skin lesions and correction of serum fatty acid 
1 3 4 
levels . 
B. Trace element deficiencies during prolonged PN are being increasingly 
reported. Acute zinc deficiency was observed in patients C, D and E. It is 
characterized by indolent, scaly, pustular eruptions surrounded by a 
brownish erythema ' . These are typically located in the comers of the 
mouth, along the nose, in the axillary and the inguinal region and the 
perineum. Serum zinc is depressed markedly, often accompanied by low serum 
alkaline phosphatase activity (a zinc methalloenzyme). Skin lesions very 
rapidly disappear after sufficient intravenous suppletion. 
Other reported trace element deficiencies include copper, chromium and 
selenium. In copper deficiency, neutrocytopenia and anaemia are the 
37 38 
predominant features ' . Chromium deficiency has been related to insulin-
resistant diabetes mellitus ' . Pain and weakness in muscles are signs 
of selenium deficiency . All these deficiency states are completely 
reversible after adequate suppletion. 
С Deficiencies of various vitamins during prolonged ИМ have been 
ported ~ . The vitamin in question wa 
PN solutions, or in insufficient amounts. 
re s generally not contained in the 
D. Patient С developed seme metabolic problems which further increased 
the hospitalization time for repeated analysis. There was permanent anaemia, 
necessitating blood transfusion every three or four months. Bone marrow 
aspirates repeatedly revealed no abnormal findings. Blood loss and 
haemolysis were ruled out, as were deficiencies of iron, folic acid, 
vitamin Bi2 and copper. 
Chronic hypalbuminaemia (albumin 25 g/1, η537) was the second unexplained 
phenomenon in patient C. There was no proteinuria and increased enteric 
protein loss was excluded. Liver biopsy after 21 years of PN revealed slight 
94 
fatty changes. At autopsy 9 months later, hepatic steatosis had become 
scmevliat more prominent. Repeatedly performed amino acid analysis of the 
amino acid solution administered confirmed the content of each individual 
amino acid, including tryptophan, as indicated by the manufacturer. However, 
before and after infusion of all PN solutions, no tryptophan could be 
detected in patient's serum. Tryptophan plays an important role in hepatic 
49 131 
albumin synthesis . Albumin synthesis, measured with the aid of I-
albumin, was evidently reduced to 8.0 g/day (normal 21.9+6.6 SD ) 5 0 . 
Intravenous supply of 2 g tryptophan/day during 2 weeks in addition to the 
usual PN solutions did not change the hypalbuminaemia but normalized the 
serum tryptophan level. Finally, metabolic end-products of tryptophan such 
as 5-hydroxyindoleacetic and kynurenic acid, could not be detected in urine. 
It is remarkable that anaemia and hypalbuminaemia were not present in 
patient B, who for 5 years received the same PN solutions as patient С 
E. Liver function disturbances and liver disease may be seen in prolonged 
PN. Extrañe fatty liver was found in patient A after 18 months of PN28. 
A relation has been established between fatty changes of the liver and PN 
2fl ?9 3Ì 51 
calories exclusively consisting of concentrated dextrose 0'^3'JJ'Ji_ 
Excessive dextrose delivery to the liver increases hepatic fatty acid and 
triglyceride synthesis. One may speculate that the increased triglyceride 
synthesis may compronise VLDL assimilation or release, causing triglyceride 
accumulation in the liver. On the other hand, VLDL assimilation may be 
reduced in the case of linoleic acid deficiency. Since linoleic acid is an 
essential constituent of phospholipids, deficiency of this fatty acid may 
impair phospholipid and subsequently VLDL synthesis. In histologically proven, 
concentrated dextrose-induced hepatic steatosis, addition of Intralipid to 
the PN scheme considerably reduced fatty changes of the liver ' . To 
prevent fatty liver, a well-balanced PN composition including fat emulsions 
can be recomnended. 
PN-related liver function disturbances are rather frequently noted ~ , 
but poorly understood. Liver function disturbances are usually modest and 
transient, even when PN is continued. There is no characteristic biochemical 
profile. Table 7.2 shows that liver function disturbances during HPN are not 
frequently encountered. 
F. Metabolic bone disease in long-term PN is not a familiar phenomenon. 
95 
It is even less well understood. Osteoporosis in patient A was probably 
related to infusion of acidic amino acid solutions, causing metabolic 
acidosis . Mobilization of bicarbonate from bone is an important mechanism 
to buffer chronic acidosis. In this situation excess of calcium and 
phosphate release from bone takes place, causing hypercalciuria . Finally, 
en 
osteoporosis results from this mechanism . Recently, peculiar bone 
diseaseCs) such as osteomalacia, increased bone turnover and osteoporosis 
have been reported after long-term PN including calcium, phosphate and 
5Θ—60 
vitamin D . No sound explanation of this syndrome has so far been found. 
7.4 Psychosocial aspects of home parenteral nutrition 
Table 7.2 indicates a lack of information on psychosocial consequences 
of HPN. A recent report has gathered sane data in this regard . During 
a mean follow-up of 7.4 months, 19 HPN patients were followed. Initially, 
reactive depressions were not infrequently observed. These reactions could 
be ascribed to the indefinite inability to eat in seme patients and to 
permanent body changes (total small bowel loss, continuous presence of a 
venacaval catheter) in others. Having adapted to the new way of life, 
attempts were undertaken to restore previous social contacts and to resume 
work. Both activities frequently caused problems and disappointments. 
Acceptance of the new situation by the family caused the least problems. 
Finally, only two out of ten principal wage-earners in this group were able 
fully to resume their former job. Experiences of Jeejeebhoy et al 6 4 and 
Fleming et al in addition to ours are somewhat better in this respect 
(table 7.2). 
7.5 Conclusion 
At present, long-term PN at heme is feasible. Related technical problems 
may be solved in the future. The main obstacle in this respect is to find 
the ideal vascular access procedure with considerably less side-effects than 
those seen with the venacaval catheter and arteriovenous conduits. Metabolic 
consequences of prolonged PN have not all been resolved. Especially the 
influence of prolonged PN on bone metabolism requires further research. 
Difficulties may also rise in patient selection for HPN. SBS and the presence 
of small bowel without function remain major indications for this treatment. 
Less well-established criteria are available for resorting to HPN in Crohn's 
disease, incurable intra-abdominal malignancy and aged SBS patients. More 
96 
experience with this valuable treatment is needed to define proper patient 
selection. 
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8 AN ACCURATE FLOW CONTROLLING DEVICE TO ADMINISTER SIMULTANEOUSLY 
DIFFERENT PARENTERAL NUTRITION SOLUTIONS. 
8.1 Introduction 
Instead of administering a concentrated dextrose solution and subsequently 
a concentrated amino acid solution for parenteral nutrition CPN), it is 
attractive to administer a homogeneous mixture of both component solutions 
to a patient. In such a mixture of two or more different component solutions 
the final concentration of each nutrient will be lower than in the 
corresponding original solution. Consequently the incidence of unwanted side 
effects such as nausea, vomiting, hyper- or hypoglycemia, which are related 
to the high concentration of the constituents will be reduced. Simultaneous 
administration of all nutrients also favors an improved nitrogen balance 
as compared to a consecutive procedure1. It is possible to compound a 
complete mixture from component solutions before the administration. The 
interaction between amino acids and dextrose referred to as the Maillard 
2 
reaction prohibits the heat sterilization of such a mixture. As a 
consequence these mixtures should be compounded under aseptic precautions. 
This aseptic compounding is a time consiming and therefore expensive process 
with a potential risk of contamination. In addition such extemporaneously 
compounded PN mixtures have a limited shelf life. 
Not only is the simultaneous administration of all nutrients favorable 
but a constant flow rate is another basic principle of PN . Conventional 
control mechanisms of delivery systems using gravity drip infusion are not 
sufficiently reliable to guarantee a constant flow rate . A common flow 
regulator in fixed position offers a constant resistance to the flowing 
fluid. When the fluid level in the container diminishes, a decrease of flow 
will be the result. Consequently, this technique necessitates repeated 
adjustment of the flow rate during infusion. 
Ideally, a PN delivery system should be simple to handle and allow the 
simultaneous infusion of sterilized dextrose, amino acids, and additives at 
a constant flow rate obtained at gravitiy drip excluding the necessity of 
any mechanical support.Recently a new disposable flow controlling device 
(Isoflux, van Leer Medical Ltd., Mijdrecht, The Netherlands) which is an 
integral part of an intravenous fluid administration set, has been 
introduced in The Netherlands. The aim of this study was to assess the 
extent to which this device could maintain a constant flow rate at gravity 
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drip during effluence and similtaneous infusion of different sterilized PN 
solutions. 
8.2 Description of the flow controlling device 
The upper part of the device (figure 8.1) its size being 50x30x10 mm, 
contains three inlets (a,b,c) to which one to three fluid containers (A, 
B) can be connected. The flow controlling device either equipped with 
steel needles or plastic spikes is adaptable to the different types of 
commercially available plastic bags. The connecting tube between the 
device and the indwelling vena cava catheter contains a drip chaniper (p) 
and a Y-connector for administration of other solutions (q). Depending on 
the position of the oval shaped flow setting valve (f) at the lower part 
of the device a flow rate between approximately 8 and 400 ml/h can be 
selected. 
Figure 8.1 
The PN delivery system 
is shown including 
connecting tubes to fluid 
containers and indwelling 
venous catheter and the 
flow controlling device. 
This is shown in greater 
detail in the rectangular 
inset (for explanation 
see text). 
Y 
юз 
A diagram of the device is shown in figure 8.2. The device contains two 
silicone rubber diaphragms(d, e). In its relaxed position the upper 
diaphragm closes the orifice(l). Each inlet orifice a,b, or с can be 
closed by inserting a nonsterile plug (h into j, figures 8.1 and 8.2). By 
connecting a fluid container to an inlet (for instance b) the weight of 
the fluid column forces the upper diaphragm to a deflected position. 
After passing the 15 у filter (k), permeable for viscous solutions and 
Intralipid but inpermeable for blood, the fluid reaches unhindered the 
left side and, via the flow setting valve (f), the right side of the lower 
diaphragm (e). The fluid force at the left side of this diaphragm is 
greater than at the right side, resulting in a deflection of the diaphragm 
to the right and in a greater or lesser closing of the outlet orifice g. By 
altering the radius of its deflection the lower diaphragm automatically 
adapts to variations in liquid level in the container. Since the infusion 
flow remains constant as long as a sufficient difference in pressure is 
maintained in the device itself, a fluid column height of at least 80 cm 
above the level of the injection site is necessary. 
Figure 8.2 
Diagram of the flow 
controlling device 
(for explanation of 
symbols see text). 
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8.3 Methods 
Experiments on effluence of anhydrous dextrose in water solutions with 
concentrations varying from 10 to 40% (w/v) and Intralipid 10% (w/v) via 
the flow controlling device were performed in vitro. The other observations 
were made on routine PN via tunnelled vena cava catheters. Three different 
solutions in 1-L bags were administered to all patients, one bag containing 
anhydrous dextrose in water 201 (w/v) with vitamins, the second anhydrous 
dextrose in water 15% (w/v) with minerals, and the third an amino acid 
solution 8% (w/v). The Isoflux administration set was compared with a 
W-type administration set including a conventional roller clamp for flow 
control. In a W-type administration set the three tubes attached to the 
PN containing bags are joined by two Y-connectors prior to the drip chamber. 
After initially having set the fluid flow by the lever stuck to the flow 
setting valve (f) accurate counting of the drip rate (drops/min) at fixed 
intervals was performed. Assessment of drop volume was not carried out, 
because in most instances drop volume slightly increases with rising drip 
rate . During the infusions the flow rate was not readjusted and in some 
infusions the weight drop of the three bags was measured using spring 
balances. 
8.4 Results 
The drip rate during the in vitro effluence experiments of the tested 
solutions did not exceed 8% of the set rate. The variation in drip rate 
in six experiments using the Isoflux system during an PN infusion period 
of 10 h and in eight similar experiments during an administration period 
of 24 h is presented in figure 8.3. These results show that the set drip 
rate is accurately kept constant within narrow limits during both infusion 
periods. An example of the satisfactory simultaneous emptying of the three 
PN containing bags is presented in figure 8.4. On the other hand, an 
unstable flow necessitating repeated flow adjustments was the result when 
the same PN solutions vere administered to the same patients using the 
W-type administration set. 
Since its introduction this new flow controlling device has been used 
at more than 3000 occasions for the administration of three different PN 
solutions. The outcome of all these PN infusions was always the same: a 
very constant flow rate during all infusions without unwanted side effects. 
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Variation of drip rate in time (mean ± SD) of six infusions during 
10 h and eight infusions during 24 h. Simultaneously administered 
were 1 L anhydrous dextrose in water 20% (w/v) , 1 L anhydrous dextrose 
in water 15% (w/v), and 1 L amino acids 8% (w/v). 
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Figure 8.4 
Weight drop of three PN-containing bags during simultaneous adminis­
tration assessed by spring balances. 
106 
8.5 Discussion 
In general, infusion pumps are succesfully used to achieve a constant 
3 Θ—11 12 
administration of PN solutions ' . Jeejeebhoy et al used a pneumatic 
pressure system for this purpose. Both energy-dependent pump and pneumatic 
systems do not simplify PN delivery systems.The Isoflux administration set 
provides a constant infusion rate at gravity drip. Since flow readjustment 
during the infusion period is not required, the system markedly relieves 
the duties of the personnel responsible for the administration of the PN 
solutions. This phenomenon makes the. system especially attractive for 
patients on home PN, where PN administration mainly takes place during the 
evening and night. Furthermore, this flow controlling device enables the 
simultaneous administration of different sterilized solutions making 
superfluous the use of expensive aseptic compounded PN mixtures. 
Two mechanisms increase the safety of the device. First, a one way valve, 
located just prior to the connecting point (figure 8.1, q) with the vena 
cava catheter, which prevents inverse blood flow. Second, when the containers 
have emptied, the upper diaphragm (figure 8.2, d) returns to the relaxed 
position closing the orifice 1 (figure 8.2) and thus abandoning the risk 
of air embolism. 
A disadvantage of the Isoflux administration set is that only bags empty 
simultaneously. Bottles, however, empty consecutively because of a different 
resistance induced by the individually varying air-inlet tubes in each of 
the bottles. Therefore, we administer fat emulsions in bottles, for 
instance Intralipid, via the Y-connector q (figure 8.1) before or after 
the infusion of the PN bags. 
In the Netherlands a daily exchange of an Isoflux administration set 
financially counterbalances the investments required for the purchase of 
infusion pumps and labor and material costs related to appropriate aseptic 
mixing of PN solutions. 
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9 HOME PARENTERAL NUTRITION VIA ARTERIOVENOUS FISTULAE. 
9.1 Introduction 
In 1968 Dudrick et al demonstrated the feasibility of the vena cava 
catheter to administer hypertonic solutions for parenteral nutrition. This 
finding was subsequently confimed by numerous reports. Especially in the 
second half of the last decade home parenteral nutrition (НШ) was 
increasingly used in nutritionally debilitated patients. Vascular access 
in patients on Н Ш is generally achieved with vena cava catheters. In this 
report we present data on 7 patients on HPN via arteriovenous fistulae (AVF), 
9.2 Patients and methods 
Since 1970 twelve patients have participated in the HPN program of this 
hospital. In seven patients HPN was administered via AVF. In four patients 
a cavai vein catheter was used and in one patient an external arteriovenous 
shunt. Characteristics of patients on Н Ш via AVF are presented in table 9.1, 
Table 9.1 
PATIENT CHARACTERISTICS 
Patient Sex Age at Indication Small bowel remnant Frequence HPN 
start HPN HPN excluding duodenum administration 
(cm) (days/week) 
SBS* 50 1 
SBS 0 7 
SBS 0 7 
SBS 50 6 
HOJ" 100 7 
scleroderma no resection 7 
small bowel 
7 m 35 HOJ 100 1 or 2 
* SBS = short bowel syndrome 
β
 HOJ = high-output end jejunostomy 
A short bowel syndrome resulted from surgery for small bowel volvulus in 
two patients, strangulation ileus in one, and mesenteric infarction in 
another patient. Two patients with Crohn's disease had a high-output end-
1 
2 
3 
4 
5 
6 
f 
f 
f 
m 
f 
m 
35 
26 
67 
17 
40 
65 
ПО 
jejunostomy due to frequent intestinal resections including proctocolectomy. 
One patient had scleroderma of the bowel resulting in severe malabsorption 
and recurrent paralytic ileus while on enteral nutrition. The average age 
at the start of HPN was 40.7 years. Alle patients were allowed to eat. Three 
patients (1, 4 and 7; table 9.1)had normal oral food intake in addition to 
parenteral nutrition. One patient (2; table 9.1) consumed some nutrients while 
the other three had hardly any oral nutrition. The solutions for parenteral 
nutrition were administered during the evening and the night. One of the 
family members took care of the insertion and removal of a no. 19 butterfly 
needle in the AW. After insertion of the needle a small sized sterile 
gauze is placed beneath the butterfly. To prevent dislodgement the butterfly, 
the underlying gauze and the needle are thoroughly fixed to the skin using 
adhesive tapes. One patient (4, table 9И) completely managed himself in this 
respect.Altogheter, 8 AVF were used in 7 patients. Two patients had a Cimino 
fistula, while in the other patients 6 bovine grafts were created. All A W 
were located at a forearm with the exception of 2 bovine grafts which had 
to be placed at a thigh because of inaccesable arm vessels. Patients were 
instructed to assess fistula function twice daily by palpation of the thrill. 
To prevent A W thrombosis all patients were receiving coumarin anticoagulants, 
mainly intravenously delivered. The effect of anticoagulant therapy was 
determined by the thrombotest (TT) method according to Owren . Optimal 
anticoagulation is achieved at a IT level between 5 and 101. 
To 6 patients a complete parenteral nutrition scheme including concentra-
CR) ted dextrose and amino acid solutions, Intralipid , minerals, vitamins 
and trace elements, were administered. One patient (7; table 9.1) received 
solutions containing almost exclusively minerals to prevent fluid and 
electrolyte imbalance. After its availability in 1978 the parenteral 
nutrition solutions were administered via a flow controlling device which 
allows the simultaneous infusion of sterilized dextrose and amino acid 
solutions in bags at a constant flow rate without the necessity of infusion 
pumps3 . 
9.3 Results 
The A W used in our HPN patients were functioning during a mean period 
of 14.3 months (range 5-54 months).Table 9.2 summarizes the events of these 
AW. Despite anticoagulant therapy A W thrombosis appeared to be the major 
complication. Three patients had an irreversible bovine graft throribosis. 
Ill 
Table 9.2 
EVENTS OF 8 AVF IN 7 HPN PATIENTS 
Patient Type AVF Location Duration HPN 
AVF via AVF(months) 
Complications 
1 
2 
3 
4 
5 
6 
7 
Cimino 
BG* 
BG 
BG 
BG 
Cimino 
BG 
BG 
arm 
arm 
arm 
thigh 
arm 
arm 
arm 
thigh 
14 
θ 
54 
5 
13 
9 
6 
5 
no 
thrombosis during septic 
shock 
twice thrombectomy(after 
42 and 51 months) 
lost after extravasation 
of parenteral nutrition 
thrombectomy after 2.5 
months 
no 
no 
thrombosis during insuf­
ficient anticoagulant 
therapy 
* BG = bovine graft 
In patient 2 a graft oblitered after 8 months use during a septic shock of 
non-graft origin. In patient 3 the bovine graft was lost after 5 months as 
a result of a local abscess and subsequently thrombosis due to extravasation 
of the parenteral nutrition solutions. However, this graft vas located very 
deep subcutaneously frequently making needle puncture troublesome. In these 
two grafts an attempt to thrombectomy was not carried out because of systemic 
or local circumstances. In patient 7 graft thrombosis occurred after 5 months 
use, while anticoagulant therapy was inadequate (IT 52%). Thrombectomy was 
unsuccessful in this graft. Another three graft thrranboses in patients 2 and 
4 were caused by intimai proliferation in the venous anastomosis and could 
be managed by thrombectomy and local repair after having been used for an 
average of 32 months. The two Cimino fistula were still patent after 14 and 
9 months HPN. 
At this moment three patients (2, 5 and 6) are still dependent on HPN via 
AVF. In two patients (1 and 4) the parenteral nutrition could be gradually 
tapered off because of increasing absorption of enteral nutrients by their 
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small bowel remnants . Patient 3 died at the age of 69 because of H W -
unrelated disease. Another patient (7) is temporarily treated with 
regular saline infusions into peripheral veins untili a recently created 
AVF can be used. 
9.4 Discussion 
Since 1970 HPN has become an established mode of nutritional support 
especially for short bowel syndrome patients. Access to the circulation 
5-7 
was initially achieved with external arteriovenous shunts . However, 
these shunts tended to obliterate early in patients with chronic intestinal 
disease . This phenomenon was attributed to the presence of damaged arm 
veins as a result of previous infusions or venipunctures and to the 
generally normal coagulation state of these patients in contrast to uremic 
patients. Accidently, a serious and even fatal arterial hemorrhage may 
occur due to disruption in tubing during the parenteral nutrition 
administration. We observed this complication in our first patient on HPN . 
Scribner did not recommend AVF for parenteral nutrition because of 
recurrent thrombosis. This statement based on only few cases may have 
prevented otheis to use parenteral nutrition via AVF.In table 9.3 experiences 
with AVF in long-term parenteral nutrition frem the literature are 
suranarized 
Table 9.3 
LITERATURE DATA OF AVF IN LONG-TERM PARENTERAL NUTRITION 
Number and type AVF Reference Mean usefulness in AVF thrombosis 
months (range) (number) 
7 Cimino 10,13,18 38,6 (2,5-86) 1 
9 Saphenous vein 13,18 24,5 (5 -84) 4 
loops 
7* Bovine grafts 11,12,13, 29,2 (5 -84) 6 
15,17,18, 
26 
4 PTFE" 14,16,18 3 (1 -5) 2 
* Experiences with another 3 bovine grafts are not included because of 
insufficient data 
PTFE = polytetrafluoroethylene 
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Altogether, 30 AVF were used in 25 patients. Mean patency of these AVF 
was 25.5 months (range 1-86). In our patients mean duration of HPN via 
AVF was 14.3 months. Obviously the best results are achieved with the 
19 direct Cimino arteriovenous anastomosis . Nearly similar results are 
obtained when using saphenous vein loops and bovine grafts. Experiences 
with polytetrafluoroethylene arteriovenous conduits are too limited for 
critical evaluation. As in our patients thrombosis was the major AVF 
complication. None of the authors mentioned the use of anticoagulant 
1 s therapy preventing AVF obliteration, although Baird suggested benefits 
of aspirin in these circumstances. 
20 
Recently Flye reported good results when creating AVF in nonuremic 
patients on aspirine and low dose subcutaneous héparine therapy. When 
comparing our results with data from the literature it seems that coumarin 
anticoagulants do not improve AVF survival. However, we feel that at 
present data on anticoagulant therapy are too limited to warrant 
discontinuation of this treatment. 
In most studies HPN is administered via vena cava catheters. When 
initially used at home, the complication rate of these catheters seemed 
to be acceptable ' . However, in some recent reports17'22-28 on 675 
central venous catheters in 381 patients, catheter problems occurred rather 
26 
frequently. In all but one of the published series the mean catheter 
survival time was less than 10 months. The overall percentage of catheter 
sepsis amounted to 16.41. Unacceptable catheter migration occurred in 
18.6°Í of all catheters, subclavian or cavai vein thrombosis in B.7% and 
definitive catheter obstruction in 8.6*o. Altogether, in 52.ЗЪ of all 
catheters serious complications were seen. 
The perfect vascular access for parenteral nutrition without any 
complication does not exist. Central venous catheters as well as AVF have 
their advantages and disadvantages. Vena cava catheters should be the 
first choice when parenteral nutrition is expected to last relatively short. 
We applied these catheters in four patients on HPN with incurable intra-
abdominal malignancies. When HFN is expected to last a long period or 
even lifelong, AVF should be considered as a valuable vascular access 
because of its relatively low complication rate. Besides, the absence of 
an external device (the catheter) increases the social activities of a 
person on HPN. The need for another person to insert and remove the needle 
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appeared to be a minor problem. Some patients are able to completely manage 
themselves. When ever possible a creation of a Cimino fistulae should be 
preferred. In case of poor arm veins a bovine graft or a saphenous vein 
loop can be reconmended. 
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C h a p t e r 10 
SUNMARY AND CONCLUSIONS 
10 SUMMARY AND CONCLUSIONS 
10.1 Summary 
Chapter 1. Introduction and aim of the study. 
Human small intestinal length in vivo probably varies between 2.5 and 4 m. 
When approximately 1 m or less small bowel is retained after extensive resec­
tion, a condition called short bowel syndrome is present. Crohn's disease, 
small bowel volvulus and mesenteric infarction are the main causes of this 
syndrane. Since the advent of parenteral nutrition, the prognosis of patients 
with a very short bowel (less than ± 40 an jejunum and or ileum left) has 
dramatically improved. Patients with 40 to 100 cm remaining jejunum and/or 
ileum can genereally be maintained with oral nutrition due to increased absorp­
tion of the small bowel remnant as result of intestinal adaptation. The aim of 
this study is to report on clinical, biochemical and nutritional aspects of 
short bowel patients on oral or parenteral nutrition, emphasizing data ση ab­
sorption of various nutrients and on bone metabolism. Furthermore, some tech­
nical aspects concerning long-term parenteral nutrition will be discussed. 
Chapter 2. Short bowel syndrome. Experiences in eight patients. 
Eight patients with a mean small bowel remnant of 60 cm (range 40 to 100 cm) 
were studied during an average of 53 months (range 24 to 87 months) after 
extensive intestinal resection. All patients took their food orally. Balance 
studies (fat, N, Ca, Mg, Ρ) were carried out an average of 30 months after 
intestinal resection. 
All patients, except of one, achieved an acceptable nutritional status, 
Frequent diarrhoea was not noted. Data from body weight, haemoglobin and 
serim albumin showed optimal intestinal adaptation to occur within two years 
after discharge from hospital. Mean nitrogen balance was slightly positive 
(0.1 g/day ± 0.6 SD). Plasma or serum levels of sodium, potassium, calcium, 
magnesium, phosphate, copper and zinc were unremarkable. Balances of calciun, 
magnesium and phosphate were about equilibrium. Serum cholesterol was 
permanently decreased, while serum levels of vitamin E and carotene were 
sligthly reduced. Mean 25-OH vitamin D- levels were clearly depressed. The 
latter observations could be ascribed to the steatorrhoea (mean fat absorption 
741 ± 18$ SD, normal ^95$). Patients in whom 15 to 20 cm ileum was retained, 
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had a normal vitamin B.2-absorption as time went by. These patients showed 
also an increase of D-xylose absorption in course of time, which was not or 
hardly not notable in patients without preserved ileum and ileocoecal valve. 
The D-xylose test and the Schilling test appeared to be useful parameters 
in patients with some preserved ileum to evaluate the absorptive capacity 
of the small bowel remnant. Important psychosocial problems did not occur. 
Chapter 3. Intestinal adaptation. 
This chapter provides a review of the literature on intestinal adaptation 
occurring after extensive small intestinal resection. A resection of at 
least 301 of the small intestine is required to provoke hyperplasia in the 
bowel remnant. The hyperplastic response in the ileum is much greater than 
that in the jejunum. Luminal nutrition is the major intestinal adaptation-
promoting factor. Nutrients may locally stimulate the release of hormones 
(especially enteroglucagon) and/or other biochemical substances (ornithine 
decarboxylase), which in turn initiate the adaptive response. Pancreaticobi­
liary secretions, whether or not released by cholecystokinin or secretin, 
probably play sane role in intestinal adaptation, although to a lesser extent 
than luminal nutrition. 
Chapter 4. Metabolic bone disease and short bowel syndrome. 
Nine patients with a disease-free, mean jejunum-ileum remnant of 52 cm 
(range 0-110 cm) were studied with regard to calcium and bone metabolism 
1 to 5 years (mean 35.3 months) after intestinal resection. Nutrition took 
place orally in seven patients (oral group), while two patients were 
dependent on parenteral nutrition for 5 and 3 years respectively (Ш 
patients). Parameters of calcium and bone metabolism as urinary 
hydroxyproline excretion and plasma or serum levels of Ca, Mg, Ρ, 
bicarbonate, alkaline phosphatase, albumin and 25-OH vitamin D were measured. 
A balance study for calcium, phosphate, magnesium and fat was carried out. 
Finally, a Ca absorption test was performed and an iliac crest bone 
biopsy was taken for histology and histcmorphometry. 
In the oral group (left with 40 to 110 an disease-free small bowel) 
patients appeared to be able to maintain an acceptable balance of Ca, Mg 
and Ρ, despite low 25-OH vitamin D levels. 
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'Ca absorption was reduced but mean calcium balance was positive probably 
due to the high dietary calcium content. Slight osteoporosis was found in 
three patients from this group, aged 59 or more. No signs of osteomalacia 
or hyperparathyroidism could be detected histomorphometrically. 
A slight metabolic acidosis, hypercalciuria, and markedly reduced serum 
25-Ж vitamin D levels were the most important abnormalities of the PN 
patients. Calcium balance was slightly negative due to a net loss of 
calcium in stools. Phosphate and magnesium balance were acceptably maintained. 
Histology revealed moderate and moderate-to-severe osteoporosis but no 
signs of osteomalacia or hyperparathyroidism which was confirmed histomor-
phometrically. Osteoporosis due to negative calcium balance was probably 
partly related to parenteral nutrition-induced slight metabolic acidosis. 
Chapter 5. Iron, zinc and copper balance in short bowel patients on oral 
nutrition. 
This chapter presents data of a five day balance study for iron, zinc 
and copper in seven patients with short bowel syndrome on oral nutrition. 
The small bowel remnant of these patients varied from 40 to 110 cm (mean 
64 an), and was radiologically normal in all patients. The study was 
carried out an average 2,7 years (range 1 to 5 years) after intestinal 
resection. Balance materials (diets, urine and stools) were measured with 
neutron activation analysis. Mean iron balance was +28,6 ymol/day (± 10.6 
SD). Mean zinc balance was +5.4 ymol/day (±6.5 SD) and mean copper balance 
+1.5 pmol/day (±2.3 SD). These results are comparable to those reported in 
healthy controls. Mean net absorption of iron was 12.6$ (±1.8 SD), while 
mean net absorption of zinc and copper was 9.31 (±3.5 SD) and 12.5$ (±5.1 
SD), respectively. When taking into account integumentary losses of these 
substances, the balance of each individual trace element remained acceptable. 
It is concluded that a satisfying iron, zinc and copper status can be 
achieved in patients after an extensive small bowel resection with a disease-
free remnant on oral nutrition. 
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Chapter 6. Metabolism of orally administered ^^"Zn in patients with short 
bowel syndrome as compared to controls subjects. 
Zinc metabolism was studied in seven patients with short bowel syndrome 
(SBS) on oral nutrition using the short-lived isotope 6 9 mZn (T! 13.9 hr). 
Results were conpared with data obtained in a healthy control group of com-
parable age. After an oral dose of Zn, activity was measured in plasma, 
erythrocytes, stools, urine, whole body and over a fixed are of the liver 
and thigh. In addition, apparent Zn absorption was calculated from whole 
body retention data. 
In two short bowel patients, results of Zn metabolism were comparable 
to those in the controls. Absorption of fat and D-xylose was also normal or 
nearly normal in these two patients. 
In the other SBS patients (abnormal SBS subgroup) the maximum level 
observed in the plasma Zn curve was 2 to 2.5 times lower than that of the 
controls. In these patinets, calculated apparent absorption was half of that 
in the normal persons. Data of cumulative faecal Zn excretion and whole 
body retention decline were in agreement with the observed reduced apparent 
absorption in the abnormal SBS subgroup. Urinary Zn excretion was 
negligible in all studied persons and patients. Uptake of Zn in the 
liver was reduced in the abnormal SBS subgroup, while flux of Zn to 
peripheral tissues (e.g. erythrocytes and thigh muscles) was identical to 
the control group and adequate. Signs of zinc deficiency were absent. It 
is concluded that the absorption of zinc in this group of patients was 
presumably still sufficient. Apparently the liver stored a smaller excess of 
absorbed zinc in the patients of the abnormal SBS subgroup. 
Chapter 7. Hone parenteral nutrition. Experience in seven patients. 
This chapter reports experiences with home parenteral nutrition (HPN) in 
seven patients who were fed parenterally for 5 to 54 months (mean 24 months): 
four patients with a short bowel syndrome, one with a high output jejmostomy, 
one with complete small bowel obstruction resulting fron irresectable tumour 
growth and one with scleroderma involving the small bowel. In four patients 
the parenteral nutrition solutions were mainly administered via an arterio-
venous fistula, in two patients via a vena cava catheter and in one patient 
via a Scribner shunt. The infusions took place during the evening and night. 
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The Isoflux flow controlling device was used to warrant a constant flow 
rate (see chapter 8). Estimated appropriate amounts of amino acids, glucose, 
lipids, vitamins and trace elements were administered. Technical problems 
were primarily related to the vascular access. A fatal haemorrhage from the 
Scribner shunt was the most serious complication. Catheter complications 
were relatively often experienced which accumulated especially in one 
patient. The least number of vascular access complications were met when 
using an arteriovenous fistula. Metabolic complications included linoleic 
acid deficiency and fatty liver in the first HPN patient (in 1971) after 
receiving fat-free solutions during some 18 months. Another patient 
suffered frem anaemia and hypoalbuminaemia of unknown origin. Zinc deficiency 
was seen three times. Three patients could fully perform their former 
jobs while on HPN. It is concluded that HPN is an important treatment for 
patients with a very short bowel or a small bowel without function. 
Chapter 8. An accurate flow controlling device to administer simultaneously 
different parenteral nutrition solutions. 
An easily operable, disposable flow controlling device is presented which 
enables a simultaneous administration of different sterilized parenteral 
nutrition (FN) solutions at a constant flow rate obtained by gravity drip 
infusion. The device contains safety mechanisms for preventing air embolism 
and inverse blood flow. Since flow readjustment during the infusion period 
is not reepjired, the system markedly relieves the duties of the personnel 
responsible for the administration of the FN solutions. This phenomenon 
makes the system especially attractive when PN administration mainly takes 
place during the evening and night as in patients on home PN. 
Chapter 9. Home parenteral nutrition via arteriovenous fistulae. 
Vascular access for home parenteral nutrition (HPN) is generally achieved 
with vena cava catheters. In sane S0% of these catheters serious complica-
tions can be expected. In this report experiences with arteriovenous fistulae 
(AVF) for the administration of parenteral nutrition at heme are described 
Altoghether, 8 AVEvwere used in 7 patients during an average 14.3 months. 
(range 5-54 months). Four patients had a short bowel syndrome, two a high-
output jejunostomy and one patient suffered from scleroderma of the small 
bowel. Despite anticoagulant therapy bovine graft thrombosis took place in 
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six instances during 100 fistula-months. Thrombectomy could successfully 
be performed in three graft thrombosis. No other AVF complications happened. 
Considering complication rates AVF are valuable alternatives for central 
venous catheters in HPN. 
10.2 Seme final remarks 
Without any doubt one can state that parenteral nutrition has dramatically 
changed the treatment of patients after an extensive small bowel resection. 
Sufficient amounts of calories, nitrogen and other essential nutrients can 
be administered in order to tide over the often troublesome postoperative 
period. This period is often characterized by massive diarrhoea with severe 
losses of various important substances, and postoperative complications 
such as intra-abdominal sepsis. Perhaps even more important is the role 
of parenteral nutrition for patients who are left with a very short bowel 
(less than approximately 40 cm small intstine). Generally, adequate 
provision of nutrients to these patients can only be achieved via the 
parenteral route. In these circumstances parenteral nutrition can take 
place best at heme. However, seme technical and metabolic problems related 
to long-term parenteral nutrition await further research. For instance, the 
ideal vascular access has not been found. Furthermore, the appropriate 
amount of several constituents of parenteral nutrition solutions has not 
been elucidated. From a metabolic point of view perhaps the most intriguing 
problem is the influence of parenteral nutrition on calcium and bone meta-
bolism. 
The future of patients who are left with some 40 to 100 cm of small bowel 
is better. They can usually be weaned off parenteral nutrition. When optimal 
intestinal adaptation had developed no severe problems have to be expected 
anymore in patients with a diseae-free small bowel remnant. With few 
exceptions, an acceptable nutritional status is achieved at that time and 
patients are not disabled by frequent diarrhoea, provided that the colon or 
a part of it is retained. The absorption of various nutrients such as 
nitrogen, calcium, magnesium, phosphate, iron, zinc and copper sufficiently 
takes place in this situation. Steatorrhoea, to a more or lesser degree, 
almost invariably will be present. It is associated with hypocholesterolaemia 
and relatively low serum levels of fat soluble vitamins. Frequent meals with 
a relatively high amount of calories, calcium and phosphate can be advised, 
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next to lactose restriction and some fat restriction. However, also short 
bowel patients generally do not comply with dietary fat restriction. There 
is hardly any place for elementary and MCT-diets. It makes sense to avoid 
high-oxalate foods and to prescribe oral calcium carbonate in case of 
hyperoxaluria. When 15 to 20 cm ileum is retained vitamin B12 suppletion 
is not warranted in most instances. Suppletion of other vitamins is rarely 
necessary and is only indicated in case of proven deficiency. 
10.3 Samenvatting 
Hoofdstuk 1. Inleiding en doel van het onderzoek 
De lengte van de dunne darm in vivo bij de mens varieert van 2,5 tot 4 m. 
Indien na een uitgebreide resectie ongeveer 1 m of minder dunne darm over-
blijft, dan ontstaat een situatie die in de engelstalige literatuur als 
"short bowel syndroom" wordt aangeduid. De belangrijkste oorzaken van dit 
syndroom zijn: de ziekte van Crohn en versterf van de dunne darm door b.v. 
een volvulus of door een afsluiting van de a. mesenterica sup. De prognose 
van patiënten die een zeer uitgebreide dunne-darmresectie ondergingen 
(minder dan ongeveer 40 cm jejunum en/of ileum over) is aanzienlijk ver-
beterd door de toepassing van parenterale voeding (hoofdstuk 7). Patienten, 
bij wie 40 à 100 cm jejunum en/of ileum gespaard is gebleven, kunnen in het 
algemeen door alleen voeding per os een voldoende voedingstoestand bereiken 
en behouden (hoofdstuk 2). Dit laatste is mogelijk door toeneming van het 
absorberend vermogen van het resterende dunne-damslijmvlies (hoofdstuk 3). 
Op enkele stofwisselingsaspecten na uitgebreide dunne-darmresecties wordt 
nader ingegaan in de hoofdstukken 4,5 en 6. Aandacht wordt o.a. geschonken 
aan de absorptie van een aantal voedingsstoffen en aan de botstofwisseling. 
Enige technische aspecten betreffende langdurige parenterale voeding kernen 
tot slot aan de orde in de hoofdstukken 8 en 9. 
Hoofdstuk 2. Zeer uitgebreide dunne-darmresecties. Ervaringen bij acht 
patiënten. 
De lotgevallen van acht patiënten met een restant dunne darm van gemid-
deld 60 cm (spreiding 40 tot 110 cm) werden nagegaan gedurende gemiddeld 
53 maanden (spreiding 24 tot 87 maanden) na een uitgebreide dunne-darmresec-
tie. Zij gebruikten allen voeding per os. Balansonderzoek (vet, stikstof, 
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Ca, Mg, Ρ) werd verricht gemiddeld 30 maanden na de resectie. 
Met uitzondering van één patiente waren alle patiënten in een heel 
acceptabele voedingstoestand. Frequente diarree kwam bij geen van hen voor. 
Uit gegevens betreffende lichaamsgewicht, serum albuminegehalte en hemoglo-
binegehalte werd geconcludeerd dat binnen twee jaar na ontslag uit het 
ziekenhuis er sprake was van een optimale darmadaptatie. De gemiddelde 
stikstofbalans was licht positief (+0.1 g/dag ± 0.6 SD). Plasma of serum-
spiegels van Na, K, Ca, Mg, P, Cu en Zn waren nauwelijks of niet afwijkend. 
De balansen van calcium, magnesium en fosfaat waren nagenoeg in evenwicht. 
Het serum cholesterolgehalte was blijvend verlaagd, terwijl de spiegels 
van vitamine E en caroteen ook aan de lage kant bleven. De gemiddelde 
25 OH vitamine D, spiegel was duidelijk verlaagd. Deze laatste waarnemingen 
konden toegeschreven worden aan de vastgestelde steatorree (gemiddelde 
vetabsorptie 74% ± 18$ SD; normaal Ì9S%). Een normale vitamine BI2 absorp-
tie werd na verloop van tijd gevonden bij patiënten, bij wie nog slechts 
15 à 20 cm ileum aanwezig was. Bij deze patiënten nam na verloop van tijd 
ook de D-xylose absorptie toe, hetgeen niet of nauwelijks werd gevonden 
bij patiënten zonder ileum. De D-xylosetest en de Schillingtest bleken 
geschikte parameters te zijn om het absorberend vermogen van het dunne-
darmrestant te beoordelen althans bij patiënten, bij wie ook enig ileum 
was behouden. Belangrijke psychosociale problemen deden zich bij deze acht 
patiënten niet voor. 
Hoofdstuk 3. Dunne-darmslijmvlies adaptatie. 
Een literatuuroverzicht betreffende dunne-darmslijmvlies adaptatie die 
ontstaat in aansluiting aan een uitgebreide dunne-darmresectie wordt gege-
ven. Een resectie van tenminste 50% van de dunne darm is nodig om hyperpla-
sie van het slijmvlies in het restant te bewerkstelligen. Het ileum heeft 
een aanzienlijk groter vermogen tot hyperplasie dan het jejunum. De belang-
rijkste factor die de adaptatie bevordert is de voedselstroom door de darm. 
Het is waarschijnlijk dat voedingsstoffen een locale stimulatie van darm-
hormonen veroorzaken (met name van enteroglucagon) en/of andere stoffen 
(het enzym ornithine decarboxylase) waardoor het proces van de intestinale 
adaptatie in gang wordt gebracht. Gal en pancreasvocht, al of niet gesecer-
neerd o.i.v. cholecystokinine of secretine, spelen waarschijnlijk ook een 
rol bij het adaptatieproces, zij het in mindere mate dan de voedselstroom 
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door de darm. 
Hoofdstuk 4. De gevolgen van zeer uitgebreide dunne-darmresecties voor de 
botstofwisseling. 
Een onderzoek naar de stofwisseling van Ca, Mg, P, vitamine D en bot werd 
uitgevoerd bij negen patiënten met een gemiddeld dunne-darmrestant van 52 cm 
(spreiding 0 tot 110 cm), 1 tot 5 jaar na een uitgebreide darmresectie. Bij 
zeven patiënten vond voeding per os plaats (orale groep), terwijl twee pa-
tienten gedurende resp. 3 en 5 jaar afhankelijk waren van parenterale 
voeding (PV patiënten). Bekende parameters van de calcium- en botstofwisse-
ling, zoals de hydroxyproline uitscheiding in de urine en plasma of serum-
spiegels van Ca, Mg, P, bicarbonaat, alkalische fosfatase, 25 OH vitamine D 
(25 OHD) en serumalbumine werden bepaald. Een balansonderzoek van Ca, Mg, 
Ρ en vet werd uitgevoerd. Tevens werd een ^'Ca absorptie-onderzoek verricht 
en werden cristabiopten genomen voor histologisch en histomorfometrisch 
onderzoek. 
De resultaten van de bovenstaande onderzoekingen waren voor wat betreft 
de orale groep bevredigend. Behoudens verlaagde 25 OH vitamine D spiegels 
waren andere parameters van de kalk- en botstofwisseling in het bloed bij 
deze patiënten normaal. De absorptie van ^'Ca was verminderd, doch de 
gemiddelde calciumbalans was positief, waarschijnlijk dankzij een betrekke-
lijk hoge calciumconsumptie. De magnesiumbalans was in evenwicht, terwijl 
de fosfaatbalans licht negatief was. Een geringe osteoporose werd aange-
troffen bij drie patiënten uit de orale groep die allen ouder dan 59 jaar 
waren. Aanwijzingen voor osteomalacie of hyperparathyreoidie ontbraken. 
Beide patiënten, die de voeding voornamelijk parenteraal kregen, hadden 
een negatieve calciumbalans, een hypercalciurie en tevens een osteoporose 
die meer uitgesproken was dan bij de patiënten uit de orale groep. Ook wa-
ren de 25 OHD spiegels flink verlaagd. Mogelijk heeft een lichte metabole 
acidóse bij de patiënten uit de parenterale groep de osteoporose bevordert. 
Zowel de fosfaat- als de magnesiumbalans waren in evenwicht of positief bij 
de beide parenteraal gevoede patiënten. Ook bij deze patiënten waren er 
geen tekenen van osteomalacie of hyperparathyreoidie bij histomorfometrisch 
onderzoek. 
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Hoofdstuk 5. De ijzer-, zink- en koperbalans bij patiënten met een klein 
restant dunne darm tijdens voeding per os. 
Gegevens worden gepresenteerd van een 5 dagen durende balansstudie be-
treffende ijzer, zink en koper bij zeven patiënten, die een uitgebreide 
dunne-darmresectie hadden ondergaan en de voeding per os tot zich namen. 
Het dunne-darmrestant van deze patiënten varieerde van 40 tot 110 cm (ge-
middeld 64 cm) en toonde röntgenologisch geen afwijkingen. Het onderzoek 
werd gemiddeld 2,7 jaar (spreiding 1 tot 5 jaar) na de resectie uitgevoerd. 
Er werd gebruik gemaakt van neutronen-activeringsanalyse ter bepaling van 
de spoorelementen in de balansonderdelen (dieet, urine en faeces). De ge-
middelde ijzerbalans was +28,6 pmol/dag (±10,6 SD). De gemiddelde zirikba-
lans bedroeg +5,4 ymol/dag (±6.5 SD) en de gemiddelde koperbalans +1,5 
ymol/dag (±2.3 SD). Deze resultaten kanen overeen met literatuurgegevens 
over balansen van deze spoorelementen, uitgevoerd bij gezonde proefpersonen. 
De gemiddelde netto-absorptie van ijzer was 12,6$ (±1,8 SD), terwijl de 
gemiddelde netto-absorptie van zink en koper respectievelijk 9,3*0 (±3,5 
SD) en 12,5$ (±5,1 SD) bedroeg. Ook wanneer men verliezen via de huid van 
deze spoorelementen in de beschouwing betrekt, dan blijft de balans van 
elk van deze drie spoorelementen heel aanvaardbaar bij deze patiënten. 
Hoofdstuk 6. De stofwisseling van per os toegediend Zn bij patiënten 
die een grote dunne-darmresectie ondergingen. 
Met behulp van Zn, een isotoop met een korte halfwaardetijd (13,9 
uur), werd het metabolisme van zink bestudeerd bij 7 patiënten met een 
short bowel syndroom (SBS), die voeding per os gebruikten. De resultaten 
werden vergeleken met gegevens van een controlegroep bestaande uit 7 ge-
zonde proefpersonen van gelijke leeftijd als de patiënten. Na orale toedie-
ning van Zn werd de activiteit ervan gemeten in plasma, erythrocyten, 
faeces, urine, boven de lever en het dijbeen en benevens van het gehele 
lichaam. Uit gegevens met betrekking tot de vermindering van de Zn-acti-
viteit in het lichaam werd de Zn absorptie berekend. De resultaten van 
het onderzoek met Zn waren bij twee patiënten vergelijkbaar met die van 
de controlegroep. Bij deze twee patiënten was de absorptie van vet en de 
D-xylose normaal of nagenoeg normaal. Bij de andere patiënten (abnormale 
SBS-subgroep) bleek de maximumwaarde van de plasma Zn-curve twee à twee-
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enhalf maal lager dan bij de controlegroep. Tevens was de berekende ab-
sorptie van Zn bij deze patiënten ongeveer de helft van die van de con-
trolegroep. In overeenstenming met deze gegevens was de significant hogere 
cumulatieve uitscheiding van Zn in de faeces en de significant snellere 
verdwijning van het Zn uit het gehele lichaam bij de abnormale SBS-
subgroep. De uitscheiding van Zn via de urine was uitermate gering zowel 
in de patiënten- als de controlegroep. De opname van Zn in de lever was 
verminderd in de abnormale SBS-subgroep terwijl het transport ervan naar 
perifere weefsels (zoals erythrocyten en spieren) identiek was aan dat van 
de controlegroep. Waarschijnlijk slaat de lever tijdelijk bepaalde hoeveel-
heid van de overmaart aan geabsorbeerd zink op, een hoeveelheid die dan bij 
de abnormale SBS-subgroep kleiner was dan bij de controlegroep. 
Hoofdstuk 7. Parenterale voeding thuis. Ervaringen bij zeven patiënten. 
Beschreven worden de lotgevallen van zeven patiënten die 5 tot 8 maanden 
(gemiddeld 24 maanden) thuis parenterale voeding kregen toegediend. Vier pa-
tienten hadden een zeer grote dunne-darmresectie ondergaan, één had een 
jejunostoma, één een totale dunne-darm-obstructie door tumorgroei en bij 
één patient met sclerodermie bestond er een zeer slechte functie van de 
dunne daim. Bij vier patiënten werden de voedingsoplossingen via een arte-
rioveneuze fistel toegediend, bij twee via een v. cava catheter en bij één 
via een Scribner shunt. Toediening vond plaats gedurende de avond en nacht. 
Gebruikt werd het Isoflux toedieningssysteem bij zes van de zeven patiënten 
waarmee het mogelijk is een constante infusiesnelheid te bereiken en ver-
schillende voedingsoplossingen gelijktijdig kunnen worden gegeven zonder 
hulp van pompen (zie ook hoofdstuk 8). Naast aminozuren, glucose, vet en 
mineralen werden vitaminen en spoorelementen toegediend. Technische proble-
men konden hoofdzakelijk aan de toedieningswegen van de parenterale voeding 
worden toegeschreven. Een dodelijke arteriele bloeding uit de Scribner 
shunt was de ernstigste complicatie. Problemen met de v. cava catheter 
kwamen relatief frequent voor, alhoewel deze zich in hoofdzaak bij één 
patiente voordeden. De minste complicaties werden gezien bij de arteriove-
neuze fistels. De ernstigste metabole conciicaties waren een linolzuurde-
ficientie en een ernstige steatosis hepatis bij een patiente die thuis on-
geveer li jaar parenterale voeding zonder vet kreeg toegediend (in 1971). 
Een andere patiente hield een, ondanks uitgebreid onderzoek, onverklaarde 
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anemie en hypoalbuminaemie. Zinkdeficientie werd drie keer waargenomen. 
Drie patiënten waren in staat on hun vroegere werk te hervatten ondanks 
het feit dat zij afhankelijk waren van parenterale voeding. Geconcludeerd 
wordt dat parenterale voeding thuis een belangrijke behandelingsmethode 
kan zijn voor patiënten bij wie de toediening van adequate hoeveelheden 
voeding per os niet of onvoldoende mogelijk is, bijvoorbeeld bij patiën-
ten die een zeer uitgebreide dunne-darmresectie ondergingen of patiënten 
met een dunne darm die niet of nauwelijks functioneert. 
Hoofdstuk 8. Een eenvoudig en nauwkeurig infuussysteem voor parenterale 
voeding. 
Een eenvoudig toedieningssysteem voor infuusvloeistoffen met een inge-
nieuze druppelregelaar wordt beschreven waardoor o.a. tegelijkertijd 
verschillende parenterale voedingsoplossingen kunnen worden toegediend 
met een constante infusiesnelheid. Het systeem bevat enkele beveiligingen 
ter voorkomint van luchtembolie en terugstremen van bloed in het systeem. 
Aangezien de infusiesnelheid na instellen van de snelheid niet meer regel-
matig gecontroleerd hoeft te worden, betekent dit systeem een aanzienlijke 
verlichting voor het personeel dat verantwoordelijk is voor de infusie. Dit 
geldt in het bijzonder voor toediening van parenterale voedingsoplossingen 
gedurende de nacht, zoals bijvoorbeeld geschiedt bij patiënten die thuis 
parenteraal gevoed worden. 
Hoofdstuk 9. Parenterale voeding, toegediend via een arterioveneuze 
fistel. 
In het algemeen maakt men gebruik van een vena cava catheter bij paren-
terale voeding. Dit gaat niet zo zelden gepaard met aanzienlijke compli-
caties. Nagegaan werd in hoeverre dit ook het geval was wanneer arterio-
veneuze fistels (А Б) werden gebruikt als toegangsweg naar de circulatie 
voor parenterale voeding. In totaal werd gebruik gemaakt van acht AVF bij 
zeven patiënten gedurende gemiddeld 14.3 maanden (spreiding 5-54 maanden). 
Vier patiënten hadden onvoldoende dunne d a m voor een normale absorptie, 
twee een jejunostomie met ernstig water- en mineralenverlies en bij één 
sclerodermie-patient was de dunne darm in het ziekteproces betrokken ge-
raakt. Ondanks therapie met anticoagulantia werd zesmaal een thrombose 
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van een bovine graft vastgesteld gedurende de 100 fistelmaanden. In 
drie gevallen kon de fistel door verwijdering van de trombus weer hersteld 
worden. Het aantal en de ernst van de complicaties in aanmerking nemende, 
kan gesteld worden dat een arterioveneuze fistel een waardevol alterna-
tief is voor de centraal veneuze catheter bij langdurige parenterale 
voeding. 
10.4 Enige conclusies tot slot. 
Zonder enige twijfel heeft parenterale voeding een belangrijke veran-
dering ten goede bewerkstelligd bij de behandeling van patiënten die een 
uitgebreide dunne-darmresectie moesten ondergaan. Voldoende calorieën, 
stikstof en andere essentiële voedingstoffen kunnen op zo'n manier toege-
diend worden ran de vaak moeizame postoperatieve fase, die niet zelden 
gekenmerkt wordt door ernstige diarree en verlies van verschillende be-
langrijke voedingsstoffen, te overbruggen. Dit geldt temeer in geval van 
postoperatieve complicaties, b.v. bij ontstekingen in de buikholte.Wel-
licht nog belangrijker is parenterale voeding voor patiënten, bij wie 
nog maar zeer weinig dunne darm over is (minder dan globaal 40 cm). In het 
algemeen kan in zo'n situatie alleen via parenterale weg een voldoende 
aanbod van voedingsstoffen plaatsvinden. Toediening van parenterale voe-
ding kan dan het beste thuis geschieden. Er kleven echter nog een aantal 
technische en metabole problemen aan langdurige parenterale voeding, die 
nader onderzoek noodzakelijk maken. De ideale toegang tot de circulatie 
is bijvoorbeeld nog niet gevonden.De juiste hoeveelheid van enkele voe-
dingsstoffen is ook niet altijd goed bekend. Een fascinerend probleem is 
het effect van parenterale voeding op de calcium- en botstofwisseling, 
waarvan nog veel onduidelijk is. 
Patienten bij wie nog 40 tot 100 on dunne darm resteert hebben betere 
vooruitzichten. Bij hen kan de parenterale voeding uiteindelijk meestal 
geheel gestaakt worden. Indien de darmadaptatie volledig tot stand is 
gekomen (na ongeveer één tot twee jaar), dan zijn geen ernstige problemen 
meer te verwachten. Behoudens een enkele uitzondering zullen de meeste 
patiënten in een redelijke tot goede voedingstoestand konen en zullen zij, 
vooropgesteld dat het colon of een ruim deel hiervan nog aanwezig is, niet 
130 
gehinderd worden door frequente diarree. Onder zulke omstandigheden is de 
absorptie van verschillende voedingsstoffen zoals stikstof, calcium, magne-
sium, fosfaat, ijzer, zink en koper voldoende. Wel zal de vetabsorptie 
vrijwel steeds meer of minder gestoord blijven. Dit gaat dan gepaard met 
een hypocholesterolemie en relatief lage serumspiegels van vet-oplösbare 
vitaminen. Frequente voedzame maaltijden, met een betrekkelijk hoog gehalte 
aan calcium en fosfaat, is dan van belang. Tevens is lactosebeperking in 
het dieet geboden alsmede enige vetbeperking. Elementaire dieten of dieten 
waarin het vet grotendeels bestaat uit korte keten vetzuren zijn zelden 
nodig of nuttig. Het is verstandig voedingsmiddelen met een hoog oxalaat-
gehalte te mijden en calciumcarbonaat per os voor te schrijven wanneer er 
sprake is van hyperoxalurie. Indien 15 tot 20 cm ileum behouden is, dan 
is regelmatige suppletie met vitamine BI2 meestal niet nodig. Toediening 
van andere vitaminen is alleen geïndiceerd bij een gebleken tekort. 
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STELLINGEN 
1 Ook zonder dunne darm is veelal een acceptabel leven mogelijk. 
dit proefschrift 
2 Indien na een uitgebreide dume-darmresectie nog slechts 20 cm ileum 
is behouden, dan is een normale vitamine BI2-absorptie mogelijk. 
dit proefschrift 
3 Patienten met een uitgebreide dunne-darmresectie kunnen een calcium-
en fosfaat-verrijkt dieet aanbevolen worden. 
dit proefschrift 
4 Het Isoflux toedieningssysteem voor parenterale voeding is een waar ei 
van Colimbus. 
dit proefschrift 
5 Indien parenterale voeding gedurende zeer lange tijd nodig is, dan vormt 
een arterioveneuze fistel een goede toegangsweg naar de circulatie. 
dit proefschrift 
6 Teveel vitamine B6 is ook niet goed. 
Schaumburg H, Kaplan J, Windebank A et al. N Engl J Med 1983; 309: 445 
7 De absorptie van koper kan in bijzondere omstandigheden door antacida 
geremd worden. 
Van Kalmthout PM, Engels LGJ, Bakker JH et al. Dig Dis Sci 1982; 27: 859 
8 Het innemen van mexiletine tijdens de maaltijden blijkt de bijwerkingen 
van dit geneesmiddel te beperken. In de bijsluiter van mexiletine wordt 
hiermee echter geen rekening gehouden. 
Dimarco JP, Gavan H, Ruskin JN. Am J Cardiol 1981; 47: 131 
9 De muziek van John Coltrane (17.7.1967t) blijft (voorlopig nog) van 
ongeëvenaarde kwaliteit. 
10 Indien tijdens endoscopie zwart gekleurd slijmvlies in de maag wordt 
waargenomen bij een patient die een geconcentreerde zuuroplossing heeft 
gedronken, dan moet ernstig rekening worden gehouden met een op handen 
zijnde maagperforatie. 
Engels LGJ, Klaassen L, Yap SH et al. Ned Tijdschr Geneeskd 1982; 126: 
1996 
11 Het werken op een polikliniek met medische dessiers bestaande uit 
losbladige vellen papier, waarop de gegevens chronologisch genoteerd 
worden, verhoogt niet het overzicht en inzicht in liet ziektebeloop van 
patiënten. 
(mededeling HMLM Bron en LP Bos, eigen waarneming) 
12 Vrijwel alle grote vernieuwers van de jazz vertonen een discontinuïteit 
in de continuïteit ten aanzien van de traditie, doch eveneens een 
herbronning op die traditie. 
De jazz-traditie speelt een doorslaggevende rol bij iedere belangrijke 
vernieuwing van deze muziek. 
LGJ Engels 
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